BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514-521. [PMID: 17332878 DOI: 10.1172/jci30587] [Cited by in Crossref: 859] [Cited by in F6Publishing: 864] [Article Influence: 57.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen F, Liu Q, Xiong Y, Xu L. Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route. Front Pharmacol 2022;13:984981. [DOI: 10.3389/fphar.2022.984981] [Reference Citation Analysis]
2 Xu Q, Sun W, Zhang J, Mei Y, Bao J, Hou S, Zhou X, Mao L. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential. Front Immunol 2022;13:963291. [DOI: 10.3389/fimmu.2022.963291] [Reference Citation Analysis]
3 Barnhoorn MC, van der Meulen-de Jong AE, Schrama ECLM, Plug LG, Verspaget HW, Fibbe WE, van Pel M, Hawinkels LJAC, Schepers K. Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells. Stem Cells Transl Med 2022:szac054. [PMID: 35984079 DOI: 10.1093/stcltm/szac054] [Reference Citation Analysis]
4 Ferrandis C, Souche R, Bardol T, Boivineau L, Fabre J, Altwegg R, Guillon F. Personalized pre-habilitation reduces anastomotic complications compared to up front surgery before ileocolic resection in high-risk patients with Crohn's disease: A single center retrospective study. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106815] [Reference Citation Analysis]
5 Núñez-sánchez MA, Melgar S, O’donoghue K, Martínez-sánchez MA, Fernández-ruiz VE, Ferrer-gómez M, Ruiz-alcaraz AJ, Ramos-molina B. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. IJMS 2022;23:8361. [DOI: 10.3390/ijms23158361] [Reference Citation Analysis]
6 Li X, Gao J, Song J, Guo K, Hou S, Wang X, He Q, Zhang Y, Zhang Y, Yang Y, Tang J, Wang H, Persson S, Huang M, Xu L, Zhong L, Li D, Liu Y, Wu H, Diao X, Chen P, Wang X, Han Y. Multi-omics analyses of 398 foxtail millet accessions reveal genomic regions associated with domestication, metabolite traits and anti-inflammatory effects. Mol Plant 2022:S1674-2052(22)00223-4. [PMID: 35808829 DOI: 10.1016/j.molp.2022.07.003] [Reference Citation Analysis]
7 Gowd V, Kanika, Jori C, Chaudhary AA, Rudayni HA, Rashid S, Khan R. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease. J Nutr Biochem 2022;109:109101. [PMID: 35777588 DOI: 10.1016/j.jnutbio.2022.109101] [Reference Citation Analysis]
8 Hu X, Yang F, Hashmi MF. Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease. Contrast Media & Molecular Imaging 2022;2022:1-8. [DOI: 10.1155/2022/3757763] [Reference Citation Analysis]
9 Yang T, Shen J. Small nucleolar RNAs and SNHGs in the intestinal mucosal barrier: Emerging insights and current roles. J Adv Res 2022:S2090-1232(22)00130-8. [PMID: 35700920 DOI: 10.1016/j.jare.2022.06.004] [Reference Citation Analysis]
10 Zhao Z, Xu S, Zhang W, Wu D, Yang G. Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications. Food Funct 2022;13:5914-24. [PMID: 35583304 DOI: 10.1039/d2fo00226d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu C, Jiang Y, Liu G, Guo Z, Jin Q, Long D, Zhou W, Qian K, Zhao H, Liu K. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD). Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115119] [Reference Citation Analysis]
12 Masaki S, Watanabe T, Arai Y, Sekai I, Hara A, Kurimoto M, Otsuka Y, Masuta Y, Yoshikawa T, Takada R, Kamata K, Minaga K, Yamashita K, Kudo M. Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4. Clin Exp Immunol 2022;207:340-50. [PMID: 35553628 DOI: 10.1093/cei/uxac005] [Reference Citation Analysis]
13 Oncel S, Basson MD. Gut homeostasis, injury, and healing: New therapeutic targets. World J Gastroenterol 2022; 28(17): 1725-1750 [DOI: 10.3748/wjg.v28.i17.1725] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nair VS, Heredia M, Samsom J, Huehn J. Impact of gut microenvironment on epigenetic signatures of intestinal T helper cell subsets. Immunology Letters 2022. [DOI: 10.1016/j.imlet.2022.04.006] [Reference Citation Analysis]
15 Bakir-gungor B, Hacılar H, Jabeer A, Nalbantoglu OU, Aran O, Yousef M. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods. PeerJ 2022;10:e13205. [DOI: 10.7717/peerj.13205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Cheatham SM, Muchhala KH, Koseli E, Jacob JC, Komla E, Negus SS, Akbarali HI. Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice. Front Pain Res (Lausanne) 2021;2:738499. [PMID: 35295474 DOI: 10.3389/fpain.2021.738499] [Reference Citation Analysis]
17 Walter RJ, Sonnentag SJ, Munoz-Sagredo L, Merkel M, Richert L, Bunert F, Heneka YM, Loustau T, Hodder M, Ridgway RA, Sansom OJ, Mely Y, Rothbauer U, Schmitt M, Orian-Rousseau V. Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop. Cell Death Dis 2022;13:168. [PMID: 35190527 DOI: 10.1038/s41419-022-04607-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lechner K, Zeeshana M, Noack M, Ali H, Neurath M, Weigmanna B. Small but powerful: Will nanoparticles be the future state‐of‐the‐art therapy for IBD? Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2043847] [Reference Citation Analysis]
19 Impellizzeri D, Fusco R, Genovese T, Cordaro M, D’amico R, Trovato Salinaro A, Ontario ML, Modafferi S, Cuzzocrea S, Di Paola R, Calabrese V, Siracusa R. Coriolus Versicolor Downregulates TLR4/NF-κB Signaling Cascade in Dinitrobenzenesulfonic Acid-Treated Mice: A Possible Mechanism for the Anti-Colitis Effect. Antioxidants 2022;11:406. [DOI: 10.3390/antiox11020406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Porpora M, Conte M, Lania G, Bellomo C, Rapacciuolo L, Chirdo FG, Auricchio R, Troncone R, Auricchio S, Barone MV, Nanayakkara M. Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes. Int J Mol Sci 2022;23:1973. [PMID: 35216089 DOI: 10.3390/ijms23041973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Simões CD, Maganinho M, Sousa AS. FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence. Eur J Nutr 2022. [PMID: 34988652 DOI: 10.1007/s00394-021-02755-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An Update of Research Animal Models of Inflammatory Bowel Disease. ScientificWorldJournal 2021;2021:7479540. [PMID: 34938152 DOI: 10.1155/2021/7479540] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Houshyar Y, Massimino L, Lamparelli LA, Danese S, Ungaro F. Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease. Front Physiol 2021;12:783295. [PMID: 34938203 DOI: 10.3389/fphys.2021.783295] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Rodrigues M, Bueno C, Lomazi EA, Fernandes MIM, Neufeld CB, D'Amico MFM, Patiño FRA. CLASSICAL SEROLOGICAL MARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN BRAZIL. Arq Gastroenterol 2021;58:495-503. [PMID: 34909856 DOI: 10.1590/S0004-2803.202100000-89] [Reference Citation Analysis]
25 Dai H, Wang L, Li L, Huang Z, Ye L. Metallothionein 1: A New Spotlight on Inflammatory Diseases. Front Immunol 2021;12:739918. [PMID: 34804020 DOI: 10.3389/fimmu.2021.739918] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
26 Zentrich E, Talbot SR, Bleich A, Häger C. Automated Home-Cage Monitoring During Acute Experimental Colitis in Mice. Front Neurosci 2021;15:760606. [PMID: 34744621 DOI: 10.3389/fnins.2021.760606] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Noto CN, Hoft SG, DiPaolo RJ. Mast Cells as Important Regulators in Autoimmunity and Cancer Development. Front Cell Dev Biol 2021;9:752350. [PMID: 34712668 DOI: 10.3389/fcell.2021.752350] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
29 Fujiwara H, Seike K, Brooks MD, Mathew AV, Kovalenko I, Pal A, Lee HJ, Peltier D, Kim S, Liu C, Oravecz-Wilson K, Li L, Sun Y, Byun J, Maeda Y, Wicha MS, Saunders TL, Rehemtulla A, Lyssiotis CA, Pennathur S, Reddy P. Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol 2021;22:1440-51. [PMID: 34686860 DOI: 10.1038/s41590-021-01048-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tanaka Y, Takeuchi H, Nakashima Y, Nagano H, Ueno T, Tomizuka K, Morita S, Emi Y, Hamai Y, Hihara J, Saeki H, Oki E, Kunisaki C, Otsuji E, Baba H, Matsubara H, Maehara Y, Kitagawa Y, Yoshida K. Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5). ESMO Open 2021;6:100277. [PMID: 34626918 DOI: 10.1016/j.esmoop.2021.100277] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Qi LL, Fan ZY, Mao HG, Wang JB. The Therapeutic Efficacy of Adipose Tissue-Derived Mesenchymal Stem Cell Conditioned Medium on Experimental Colitis Was Improved by the Serum From Colitis Rats. Front Bioeng Biotechnol 2021;9:694908. [PMID: 34604183 DOI: 10.3389/fbioe.2021.694908] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Sobah ML, Liongue C, Ward AC. SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer. Front Med (Lausanne) 2021;8:727987. [PMID: 34604264 DOI: 10.3389/fmed.2021.727987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yağiz B, Coşkun BN, Ocak T, Güner A, Macunluoglu A, Pehlivan Y, Kiyici M, Yazici S, Başkan E, Dalkiliç HE. Five Years’ Experience of Multidisciplinary Approach to Chronic Inflammatory Diseases by Rheumatology, Dermatology and Gastroenterology Departments. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.958247] [Reference Citation Analysis]
34 Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, Liu T, Gong P, Zhang L, Cao F, Pastorin G, Lee CN, Chen X, Wang JW, Yi H. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics 2021;11:8570-86. [PMID: 34373759 DOI: 10.7150/thno.62046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
35 Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res 2021;2021:8030297. [PMID: 34337079 DOI: 10.1155/2021/8030297] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Iwata K, Mikami Y, Kato M, Yahagi N, Kanai T. Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery. Inflamm Regen 2021;41:21. [PMID: 34261521 DOI: 10.1186/s41232-021-00174-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sajid-Ur-Rehman M, Ishtiaq S, Khan MA, Alshamrani M, Younus M, Shaheen G, Abdullah M, Sarwar G, Khan MS, Javed F. Phytochemical profiling, in vitro and in vivo anti-inflammatory, analgesic and antipyretic potential of Sesuvium sesuvioides (Fenzl) Verdc. (Aizoaceae). Inflammopharmacology 2021;29:789-800. [PMID: 34061285 DOI: 10.1007/s10787-021-00824-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci 2021;21:270-83. [PMID: 33052081 DOI: 10.17305/bjbms.2020.5016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ashaolu TJ, Fernández-tomé S. Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics. Trends in Food Science & Technology 2021;112:764-79. [DOI: 10.1016/j.tifs.2021.04.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Honjo H, Watanabe T, Kamata K, Minaga K, Kudo M. RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:650403. [PMID: 33935757 DOI: 10.3389/fphar.2021.650403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
42 Schmitt H, Neurath MF, Atreya R. Role of the IL23/IL17 Pathway in Crohn's Disease. Front Immunol 2021;12:622934. [PMID: 33859636 DOI: 10.3389/fimmu.2021.622934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
43 Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 2021;9:697. [PMID: 33801755 DOI: 10.3390/microorganisms9040697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
44 Xu Q, Zhou X, Strober W, Mao L. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules 2021;26:1725. [PMID: 33808793 DOI: 10.3390/molecules26061725] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
45 Lu K, Zhou J, Deng J, Li Y, Wu C, Bao J. Periplaneta americana Oligosaccharides Exert Anti-Inflammatory Activity through Immunoregulation and Modulation of Gut Microbiota in Acute Colitis Mice Model. Molecules 2021;26:1718. [PMID: 33808686 DOI: 10.3390/molecules26061718] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Zhang L, Wu X, Yang R, Chen F, Liao Y, Zhu Z, Wu Z, Sun X, Wang L. Effects of Berberine on the Gastrointestinal Microbiota. Front Cell Infect Microbiol 2020;10:588517. [PMID: 33680978 DOI: 10.3389/fcimb.2020.588517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
47 Pang L, Huynh J, Alorro MG, Li X, Ernst M, Chand AL. STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis. Biomedicines 2021;9:187. [PMID: 33673239 DOI: 10.3390/biomedicines9020187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Kang S, Song Y, Jeon Y, Kim D, Park J, Soh J, Lee J, Kitalong C, Kim W, An H, Chang J, Lee J, Jin J. Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia. Applied Sciences 2021;11:1545. [DOI: 10.3390/app11041545] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
49 Han Z, Wang H, Guo D, Zhang J. Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis. Aging (Albany NY) 2021;13:5087-103. [PMID: 33535180 DOI: 10.18632/aging.202427] [Reference Citation Analysis]
50 Yoshimura T, Mitsuyama K, Sakemi R, Takedatsu H, Yoshioka S, Kuwaki K, Mori A, Fukunaga S, Araki T, Morita M, Tsuruta K, Yamasaki H, Torimura T. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease. Mediators Inflamm 2021;2021:8825374. [PMID: 33623482 DOI: 10.1155/2021/8825374] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
51 Zhong YB, Kang ZP, Zhou BG, Wang HY, Long J, Zhou W, Zhao HM, Liu DY. Curcumin Regulated the Homeostasis of Memory T Cell and Ameliorated Dextran Sulfate Sodium-Induced Experimental Colitis. Front Pharmacol 2020;11:630244. [PMID: 33597887 DOI: 10.3389/fphar.2020.630244] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
52 Fang W, Zhao P, Shen A, Liu L, Chen H, Chen Y, Peng J, Sferra TJ, Sankararaman S, Luo Y, Ke X. Effects of Qing Hua Chang Yin on lipopolysaccharide‑induced intestinal epithelial tight junction injury in Caco‑2 cells. Mol Med Rep 2021;23:205. [PMID: 33495820 DOI: 10.3892/mmr.2021.11844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Aggarwal A, Verma S, Ghai R, Nagarajan K. Potential of fruits and vegetables to treat inflammatory conditions. Materials Today: Proceedings 2021;47:127-34. [DOI: 10.1016/j.matpr.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Algieri F, Garrido-Mesa J, Vezza T, Rodríguez-Sojo MJ, Rodríguez-Cabezas ME, Olivares M, García F, Gálvez J, Morón R, Rodríguez-Nogales A. Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs. Eur J Nutr 2021;60:2537-51. [PMID: 33216193 DOI: 10.1007/s00394-020-02441-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Dai C, Huang YH, Jiang M, Sun MJ. Nonclostridium difficile enteric infection and the risk of developing inflammatory bowel disease: A systematic review and meta-analysis. Saudi J Gastroenterol 2020. [PMID: 33154203 DOI: 10.4103/sjg.SJG_231_20] [Reference Citation Analysis]
57 Zorzi F, Calabrese E, Di Fusco D, De Cristofaro E, Biancone L, Casella S, Palmieri G, Monteleone G. High Smad7 in the early post-operative recurrence of Crohn's disease. J Transl Med 2020;18:395. [PMID: 33076905 DOI: 10.1186/s12967-020-02558-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Crump GM, Zhou J, Mashayekh S, Grimes CL. Revisiting peptidoglycan sensing: interactions with host immunity and beyond. Chem Commun (Camb) 2020;56:13313-22. [PMID: 33057506 DOI: 10.1039/d0cc02605k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Miller MO, Kashyap PC, Becker SL, Thomas RM, Hodin RA, Miller G, Hundeyin M, Pushalkar S, Cohen D, Saxena D, Shogan BD, Morris-Stiff GJ. SSAT State-of-the-Art Conference: Advancements in the Microbiome. J Gastrointest Surg 2021;25:1885-95. [PMID: 32989690 DOI: 10.1007/s11605-020-04551-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Shodeinde AB, Murphy AC, Oldenkamp HF, Potdar AS, Ludolph CM, Peppas NA. Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases. Adv Funct Mater 2020;30:1909556. [PMID: 33071713 DOI: 10.1002/adfm.201909556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
61 Allais L, Verschuere S, Maes T, De Smet R, Devriese S, Gonzales GB, Peeters H, Van Crombruggen K, Bachert C, De Vos M, Brusselle GG, Bracke KR, Cuvelier CA, Laukens D. Translational research into the effects of cigarette smoke on inflammatory mediators and epithelial TRPV1 in Crohn's disease. PLoS One 2020;15:e0236657. [PMID: 32760089 DOI: 10.1371/journal.pone.0236657] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
62 Park SY. Surgical Treatment of Upper Gastrointestinal Tract Crohn Disease: A Long Way to Go to Identify the Optimal Method. Ann Coloproctol 2020;36:207-8. [PMID: 32919433 DOI: 10.3393/ac.2020.07.03] [Reference Citation Analysis]
63 Yan F, Polk DB. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis. Front Immunol 2020;11:1428. [PMID: 32719681 DOI: 10.3389/fimmu.2020.01428] [Cited by in Crossref: 13] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
64 Kwak MS, Lee HH, Cha JM, Shin HP, Jeon JW, Yoon JY. Novel candidate drugs in anti-tumor necrosis factor refractory Crohn's diseases: in silico study for drug repositioning. Sci Rep 2020;10:10708. [PMID: 32612148 DOI: 10.1038/s41598-020-67801-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Adjouzem CF, Gilbert A, Mbiantcha M, Yousseu Nana W, Matah Marthe Mba V, Djuichou Nguemnang SF, Tsafack EG, Atsamo AD. Effects of Aqueous and Methanolic Extracts of Stem Bark of Alstonia boonei De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats. Evid Based Complement Alternat Med 2020;2020:4918453. [PMID: 32565862 DOI: 10.1155/2020/4918453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
66 Despalatović BR, Babić M, Bratanić A, Tonkić A, Vilović K. Difference in Presence and Number of CD83+ Dendritic Cells in Patients with Ulcerative Colitis and Crohn's Disease. Sci Rep 2020;10:10055. [PMID: 32572123 DOI: 10.1038/s41598-020-67149-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:192. [PMID: 32552882 DOI: 10.1186/s12876-020-01339-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
68 Wang J, Chen WD, Wang YD. The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages. Front Microbiol 2020;11:1065. [PMID: 32582063 DOI: 10.3389/fmicb.2020.01065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 63] [Article Influence: 11.5] [Reference Citation Analysis]
69 Kwak MS, Cha JM, Shin HP, Jeon JW, Yoon JY. Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease. Front Microbiol 2020;11:1162. [PMID: 32582102 DOI: 10.3389/fmicb.2020.01162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
70 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
71 Garcia PM, Moore J, Kahan D, Hong MY. Effects of Vitamin D Supplementation on Inflammation, Colonic Cell Kinetics, and Microbiota in Colitis: A Review. Molecules 2020;25:E2300. [PMID: 32422882 DOI: 10.3390/molecules25102300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
72 Ma S, Yeom J, Lim YH. Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model. Sci Rep 2020;10:5523. [PMID: 32218552 DOI: 10.1038/s41598-020-62497-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
73 Cochran KE, Lamson NG, Whitehead KA. Expanding the utility of the dextran sulfate sodium (DSS) mouse model to induce a clinically relevant loss of intestinal barrier function. PeerJ. 2020;8:e8681. [PMID: 32195049 DOI: 10.7717/peerj.8681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
74 Tashita C, Hoshi M, Hirata A, Nakamoto K, Ando T, Hattori T, Yamamoto Y, Tezuka H, Tomita H, Hara A, Saito K. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice. World J Gastroenterol 2020; 26(9): 918-932 [PMID: 32206003 DOI: 10.3748/wjg.v26.i9.918] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
75 Recinella L, Chiavaroli A, Ronci M, Menghini L, Brunetti L, Leone S, Tirillini B, Angelini P, Covino S, Venanzoni R, Zengin G, Di Simone S, Ciferri MC, di Giacomo V, Cataldi A, Rapino M, Valerio VD, Orlando G, Ferrante C. Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation. Antioxidants (Basel) 2020;9:E168. [PMID: 32085616 DOI: 10.3390/antiox9020168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
76 Mennillo E, Yang X, Paszek M, Auwerx J, Benner C, Chen S. NCoR1 Protects Mice From Dextran Sodium Sulfate-Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult. Cell Mol Gastroenterol Hepatol 2020;10:133-47. [PMID: 32044398 DOI: 10.1016/j.jcmgh.2020.01.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 Li N, Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease. World J Gastroenterol 2020; 26(5): 478-498 [PMID: 32089625 DOI: 10.3748/wjg.v26.i5.478] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wu H, Rao Q, Ma GC, Yu XH, Zhang CE, Ma ZJ. Effect of Triptolide on Dextran Sodium Sulfate-Induced Ulcerative Colitis and Gut Microbiota in Mice. Front Pharmacol 2019;10:1652. [PMID: 32063856 DOI: 10.3389/fphar.2019.01652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
79 Magrone T, Magrone M, Russo MA, Jirillo E. Recent Advances on the Anti-Inflammatory and Antioxidant Properties of Red Grape Polyphenols: In Vitro and In Vivo Studies. Antioxidants (Basel) 2019;9:E35. [PMID: 31906123 DOI: 10.3390/antiox9010035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
80 Liu H, Liang Z, Wang F, Zhou C, Zheng X, Hu T, He X, Wu X, Lan P. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight 2019;4:131273. [PMID: 31689240 DOI: 10.1172/jci.insight.131273] [Cited by in Crossref: 43] [Cited by in F6Publishing: 71] [Article Influence: 14.3] [Reference Citation Analysis]
81 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 180] [Article Influence: 31.7] [Reference Citation Analysis]
82 Scott NA, Mann ER. Regulation of mononuclear phagocyte function by the microbiota at mucosal sites. Immunology 2020;159:26-38. [PMID: 31777068 DOI: 10.1111/imm.13155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
83 Zhu J, Wang Z, Chen F, Liu C. Identification of genes and functional coexpression modules closely related to ulcerative colitis by gene datasets analysis. PeerJ 2019;7:e8061. [PMID: 31741804 DOI: 10.7717/peerj.8061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
84 Sun H, Kuk W, Rivera-Nieves J, Lopez-Ramirez MA, Eckmann L, Ginsberg MH. β7 Integrin Inhibition Can Increase Intestinal Inflammation by Impairing Homing of CD25hiFoxP3+ Regulatory T Cells. Cell Mol Gastroenterol Hepatol 2020;9:369-85. [PMID: 31707128 DOI: 10.1016/j.jcmgh.2019.10.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
85 Cheru L, Saylor CF, Lo J. Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation. Curr Obes Rep 2019;8:165-74. [PMID: 30847735 DOI: 10.1007/s13679-019-00332-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
86 Tandra N, Wu P, Hu X, Mao F, Xu W, Qian H. Extracellular Vesicles: A New Nano Tool for the Treatment of Inflammatory Bowel Diseases. CNANO 2019;15:589-95. [DOI: 10.2174/1573413715666190411141126] [Reference Citation Analysis]
87 Silva I, Pinto R, Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med 2019;8:E1574. [PMID: 31581545 DOI: 10.3390/jcm8101574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
88 da Costa Gonçalves F, Paz AH. Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases. World J Stem Cells 2019; 11(9): 618-633 [PMID: 31616539 DOI: 10.4252/wjsc.v11.i9.618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
89 Schmitt H, Neufert C, Neurath MF, Atreya R. Resolution of Crohn's disease. Semin Immunopathol 2019;41:737-46. [PMID: 31552470 DOI: 10.1007/s00281-019-00756-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
90 Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
91 Sevencan NO, Isler M, Kapucuoglu FN, Senol A, Kayhan B, Kiztanir S, Kockar MC. Dose-dependent effects of kefir on colitis induced by trinitrobenzene sulfonic acid in rats. Food Sci Nutr 2019;7:3110-8. [PMID: 31572604 DOI: 10.1002/fsn3.1174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
92 Swanson KD, Theodorou E, Kokkotou E. Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm. Curr Opin Gastroenterol 2018;34:384-91. [PMID: 30188406 DOI: 10.1097/MOG.0000000000000485] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 201] [Article Influence: 42.3] [Reference Citation Analysis]
94 Ke K, Chen TH, Arra M, Mbalaviele G, Swarnkar G, Abu-Amer Y. Attenuation of NF-κB in Intestinal Epithelial Cells Is Sufficient to Mitigate the Bone Loss Comorbidity of Experimental Mouse Colitis. J Bone Miner Res 2019;34:1880-93. [PMID: 31107556 DOI: 10.1002/jbmr.3759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
95 Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, Vega MCG, Govillard L, Tackett MR, Tejada G, Gónzalez E, Anguita J, Bujanda L, Orcasitas AMC, Aransay AM, Maíz O, López de Munain A, Falcón-Pérez JM. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.EBioMedicine. 2019;46:499-511. [PMID: 31327695 DOI: 10.1016/j.ebiom.2019.07.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
96 Lo Presti A, Zorzi F, Del Chierico F, Altomare A, Cocca S, Avola A, De Biasio F, Russo A, Cella E, Reddel S, Calabrese E, Biancone L, Monteleone G, Cicala M, Angeletti S, Ciccozzi M, Putignani L, Guarino MPL. Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. Front Microbiol. 2019;10:1655. [PMID: 31379797 DOI: 10.3389/fmicb.2019.01655] [Cited by in Crossref: 53] [Cited by in F6Publishing: 85] [Article Influence: 17.7] [Reference Citation Analysis]
97 Volarevic V, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells 2019;8:E709. [PMID: 31336879 DOI: 10.3390/cells8070709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
98 Meriwether D, Sulaiman D, Volpe C, Dorfman A, Grijalva V, Dorreh N, Solorzano-Vargas RS, Wang J, O'Connor E, Papesh J, Larauche M, Trost H, Palgunachari MN, Anantharamaiah GM, Herschman HR, Martin MG, Fogelman AM, Reddy ST. Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. J Clin Invest 2019;129:3670-85. [PMID: 31184596 DOI: 10.1172/JCI123700] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
99 Azzman N. Crohn's Disease: Potential Drugs for Modulation of Autophagy. Medicina (Kaunas) 2019;55:E224. [PMID: 31146413 DOI: 10.3390/medicina55060224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
100 Amara J, Saliba Y, Hajal J, Smayra V, Bakhos JJ, Sayegh R, Fares N. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Dig Dis Sci 2019;64:3122-33. [PMID: 31115725 DOI: 10.1007/s10620-019-05675-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
101 Melhem H, Kaya B, Ayata CK, Hruz P, Niess JH. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. Cells. 2019;8. [PMID: 31091682 DOI: 10.3390/cells8050450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
102 Sun M, Du B, Shi Y, Lu Y, Zhou Y, Liu B. Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis. Med Sci Monit 2019;25:3303-15. [PMID: 31055592 DOI: 10.12659/MSM.916009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
103 Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, Hildner K, Waldner MJ, Mudter J, Hartmann A, Grützmann R, Neufert C, Münster T, Neurath MF, Atreya R. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease. Gut 2019;68:814-28. [PMID: 29848778 DOI: 10.1136/gutjnl-2017-315671] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 25.3] [Reference Citation Analysis]
104 Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Front Pharmacol 2019;10:314. [PMID: 31068803 DOI: 10.3389/fphar.2019.00314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
105 Burge K, Gunasekaran A, Eckert J, Chaaban H. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int J Mol Sci 2019;20:E1912. [PMID: 31003422 DOI: 10.3390/ijms20081912] [Cited by in Crossref: 37] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
106 Rasmussen NF, Rubin KH, Stougaard M, Tjønneland A, Stenager E, Lund Hetland M, Glintborg B, Bygum A, Andersen V. Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish 'Diet, Cancer and Health' cohort (PROCID-DCH): protocol. BMJ Open 2019;9:e024555. [PMID: 30928934 DOI: 10.1136/bmjopen-2018-024555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
107 Thomas KS, Owen KA, Conger K, Llewellyn RA, Bouton AH, Casanova JE. Non-redundant functions of FAK and Pyk2 in intestinal epithelial repair. Sci Rep 2019;9:4497. [PMID: 30872746 DOI: 10.1038/s41598-019-41116-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, Klenske E, Erickson R, Chiu H, Reed C, Chung S, Neufert C, Atreya I, McBride J, Neurath MF, Zundler S. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol 2019;10:39. [PMID: 30774593 DOI: 10.3389/fphar.2019.00039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
109 Hu F, Xue Y, Guo C, Liu J, Mao S. The response of ruminal fermentation, epithelium-associated microbiota, and epithelial barrier function to severe feed restriction in pregnant ewes. J Anim Sci 2018;96:4293-305. [PMID: 30272228 DOI: 10.1093/jas/sky306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
110 da Silva VC, de Araújo AA, de Souza Araújo DF, Souza Lima MCJ, Vasconcelos RC, de Araújo Júnior RF, Langasnner SMZ, de Freitas Fernandes Pedrosa M, de Medeiros CACX, Guerra GCB. Intestinal Anti-Inflammatory Activity of the Aqueous Extract from Ipomoea asarifolia in DNBS-Induced Colitis in Rats. Int J Mol Sci 2018;19:E4016. [PMID: 30545135 DOI: 10.3390/ijms19124016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
111 Yi J, Bergstrom K, Fu J, Shan X, McDaniel JM, McGee S, Qu D, Houchen CW, Liu X, Xia L. Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitis. Cell Death Differ 2019;26:1656-69. [PMID: 30478383 DOI: 10.1038/s41418-018-0237-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
112 Nunes NS, Kim S, Sundby M, Chandran P, Burks SR, Paz AH, Frank JA. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J Gastroenterol 2018; 24(38): 4341-4355 [PMID: 30344419 DOI: 10.3748/wjg.v24.i38.4341] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
113 Kim KY, Oh TW, Do HJ, Yang JH, Yang IJ, Jeon YH, Go YH, Ahn SC, Ma JY, Park KI. Acer palmatum thumb. Ethanol Extract Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation. J Immunol Res. 2018;2018:5718396. [PMID: 30402509 DOI: 10.1155/2018/5718396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
114 Kelly D, Kotliar M, Woo V, Jagannathan S, Whitt J, Moncivaiz J, Aronow BJ, Dubinsky MC, Hyams JS, Markowitz JF, Baldassano RN, Stephens MC, Walters TD, Kugathasan S, Haberman Y, Sundaram N, Rosen MJ, Helmrath M, Karns R, Barski A, Denson LA, Alenghat T. Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease. JCI Insight 2018;3:122104. [PMID: 30232290 DOI: 10.1172/jci.insight.122104] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
115 Mateus V, Rocha J, Mota-Filipe H, Sepodes B, Pinto R. Hemin reduces inflammation associated with TNBS-induced colitis. Clin Exp Gastroenterol 2018;11:325-34. [PMID: 30271188 DOI: 10.2147/CEG.S166197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
116 Wu T, Wang C, Wang W, Hui Y, Zhang R, Qiao L, Dai Y. Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis. Oncoimmunology 2018;7:e1498437. [PMID: 30377563 DOI: 10.1080/2162402X.2018.1498437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
117 Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
118 Sedda S, Franzè E, Bevivino G, Di Giovangiulio M, Rizzo A, Colantoni A, Ortenzi A, Grasso E, Giannelli M, Sica GS, Fantini MC, Monteleone G. Reciprocal Regulation Between Smad7 and Sirt1 in the Gut. Front Immunol 2018;9:1854. [PMID: 30147698 DOI: 10.3389/fimmu.2018.01854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
119 Toledo-Mauriño JJ, Furuzawa-Carballeda J, Villeda-Ramírez MA, Fonseca-Camarillo G, Meza-Guillen D, Barreto-Zúñiga R, Yamamoto-Furusho JK. The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis. Mediators Inflamm 2018;2018:6570371. [PMID: 30150894 DOI: 10.1155/2018/6570371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
120 Grill M, Hasenoehrl C, Storr M, Schicho R. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Med Cannabis Cannabinoids 2018;1:28-35. [PMID: 34676319 DOI: 10.1159/000489036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Zhou G, Yu L, Fang L, Yang W, Yu T, Miao Y, Chen M, Wu K, Chen F, Cong Y, Liu Z. CD177+ neutrophils as functionally activated neutrophils negatively regulate IBD. Gut 2018;67:1052-63. [PMID: 28468761 DOI: 10.1136/gutjnl-2016-313535] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 20.0] [Reference Citation Analysis]
122 Yoon H, Schaubeck M, Lagkouvardos I, Blesl A, Heinzlmeir S, Hahne H, Clavel T, Panda S, Ludwig C, Kuster B, Manichanh C, Kump P, Haller D, Hörmannsperger G. Increased Pancreatic Protease Activity in Response to Antibiotics Impairs Gut Barrier and Triggers Colitis. Cell Mol Gastroenterol Hepatol 2018;6:370-388.e3. [PMID: 30182050 DOI: 10.1016/j.jcmgh.2018.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
123 Celiberto LS, Graef FA, Healey GR, Bosman ES, Jacobson K, Sly LM, Vallance BA. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology 2018;155:36-52. [PMID: 29693729 DOI: 10.1111/imm.12939] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
124 Tanaka T, Kobunai T, Yamamoto Y, Emoto S, Murono K, Kaneko M, Sasaki K, Otani K, Nishikawa T, Kawai K, Hata K, Nozawa H, Watanabe T. Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step. Cancer Genomics Proteomics 2017;14:341-8. [PMID: 28871001 DOI: 10.21873/cgp.20044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
125 Wang D, DuBois RN. Role of prostanoids in gastrointestinal cancer. J Clin Invest 2018;128:2732-42. [PMID: 29733297 DOI: 10.1172/JCI97953] [Cited by in Crossref: 48] [Cited by in F6Publishing: 60] [Article Influence: 12.0] [Reference Citation Analysis]
126 Wang Z, Wu X, Wang CL, Wang L, Sun C, Zhang DB, Liu JL, Liang YN, Tang DX, Tang ZS. Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways. Molecules 2018;23:E1062. [PMID: 29724065 DOI: 10.3390/molecules23051062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
127 Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:400. [PMID: 29545807 DOI: 10.3389/fimmu.2018.00400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
128 Wu W, Chen F, Liu Z, Cong Y. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1473-82. [PMID: 27057688 DOI: 10.1097/MIB.0000000000000775] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
129 Christensen R, Heitmann BL, Andersen KW, Nielsen OH, Sørensen SB, Jawhara M, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Bennike TB, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Boye M, Werner L, Nielsen CL, Munk HL, Nexøe AB, Ellingsen T, Holmskov U, Kjeldsen J, Andersen V. Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine. BMJ Open 2018;8:e018166. [PMID: 29439003 DOI: 10.1136/bmjopen-2017-018166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
130 Sun Y, Zhao Y, Wang X, Zhao L, Li W, Ding Y, Kong L, Guo Q, Lu N. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway. Oncotarget 2016;7:34300-15. [PMID: 27102438 DOI: 10.18632/oncotarget.8815] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
131 Burger E, Araujo A, López-Yglesias A, Rajala MW, Geng L, Levine B, Hooper LV, Burstein E, Yarovinsky F. Loss of Paneth Cell Autophagy Causes Acute Susceptibility to Toxoplasma gondii-Mediated Inflammation. Cell Host Microbe 2018;23:177-190.e4. [PMID: 29358083 DOI: 10.1016/j.chom.2018.01.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 13.3] [Reference Citation Analysis]
132 Li N, Shi RH. Updated review on immune factors in pathogenesis of Crohn’s disease. World J Gastroenterol 2018; 24(1): 15-22 [PMID: 29358878 DOI: 10.3748/wjg.v24.i1.15] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
133 Tong M, Yi L, Sun N, Cheng Y, Cao Z, Wang J, Li S, Lin P, Sun Y, Cheng S. Quantitative Analysis of Cellular Proteome Alterations in CDV-Infected Mink Lung Epithelial Cells. Front Microbiol 2017;8:2564. [PMID: 29312244 DOI: 10.3389/fmicb.2017.02564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Tantravedi S, Vesuna F, Winnard PT, Van Voss MRH, Van Diest PJ, Raman V. Role of DDX3 in the pathogenesis of inflammatory bowel disease. Oncotarget. 2017;8:115280-115289. [PMID: 29383159 DOI: 10.18632/oncotarget.23323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
135 Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9:7204-18. [PMID: 29467962 DOI: 10.18632/oncotarget.23208] [Cited by in Crossref: 821] [Cited by in F6Publishing: 722] [Article Influence: 164.2] [Reference Citation Analysis]
136 Matsumoto K, Yamaba R, Inoue K, Utsumi D, Tsukahara T, Amagase K, Tominaga M, Kato S. Transient receptor potential vanilloid 4 channel regulates vascular endothelial permeability during colonic inflammation in dextran sulphate sodium-induced murine colitis. Br J Pharmacol 2018;175:84-99. [PMID: 29053877 DOI: 10.1111/bph.14072] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
137 Fukunaga S, Kuwaki K, Mitsuyama K, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Mori A, Kakuma T, Tsuruta O, Torimura T. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization. Int J Mol Med 2018;41:107-18. [PMID: 29115397 DOI: 10.3892/ijmm.2017.3244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
138 Yuksel M, Ates I, Kaplan M, Arikan MF, Ozin YO, Kilic ZMY, Topcuoglu C, Kayacetin E. Is Oxidative Stress Associated with Activation and Pathogenesis of Inflammatory Bowel Disease? J Med Biochem 2017;36:341-8. [PMID: 30581331 DOI: 10.1515/jomb-2017-0013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
139 Alaarg A, Pérez-Medina C, Metselaar JM, Nahrendorf M, Fayad ZA, Storm G, Mulder WJM. Applying nanomedicine in maladaptive inflammation and angiogenesis. Adv Drug Deliv Rev 2017;119:143-58. [PMID: 28506745 DOI: 10.1016/j.addr.2017.05.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
140 Eissa N, Hussein H, Kermarrec L, Grover J, Metz-Boutigue ME, Bernstein CN, Ghia JE. Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages. Front Immunol. 2017;8:1131. [PMID: 28951733 DOI: 10.3389/fimmu.2017.01131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
141 Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 2017; 23(33): 6016-6029 [PMID: 28970718 DOI: 10.3748/wjg.v23.i33.6016] [Cited by in CrossRef: 310] [Cited by in F6Publishing: 280] [Article Influence: 62.0] [Reference Citation Analysis]
142 Salgado VCL, Luiz RR, Boechat N, Schorr BC, Leão IS, Nunes T, Zaltman C. Crohn’s disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil. World J Gastroenterol 2017; 23(30): 5549-5556 [PMID: 28852314 DOI: 10.3748/wjg.v23.i30.5549] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
143 Yamauchi R, Kominato K, Mitsuyama K, Takedatsu H, Yoshioka S, Kuwaki K, Yamasaki H, Fukunaga S, Mori A, Akiba J, Tsuruta O, Torimura T. Stereomicroscopic features of colitis-associated tumors in mice: Evaluation of pit pattern. Oncol Lett 2017;14:3675-82. [PMID: 28927130 DOI: 10.3892/ol.2017.6645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
144 Eckel A, Lee D, Deutsch G, Maxin A, Oda D. Oral manifestations as the first presenting sign of Crohn's disease in a pediatric patient. J Clin Exp Dent 2017;9:e934-8. [PMID: 28828164 DOI: 10.4317/jced.53914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
145 Attarwala H, Han M, Kim J, Amiji M. Oral nucleic acid therapy using multicompartmental delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10. [PMID: 28544521 DOI: 10.1002/wnan.1478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
146 Andersen V, Holmskov U, Sørensen SB, Jawhara M, Andersen KW, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Nielsen OH, Christensen R, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Heitmann B, Boye M, Nielsen CL, Werner L, Kjeldsen J, Ellingsen T. A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine. Nutrients 2017;9:E499. [PMID: 28505128 DOI: 10.3390/nu9050499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
147 Carvalho RDO, do Carmo FLR, de Oliveira Junior A, Langella P, Chatel JM, Bermúdez-Humarán LG, Azevedo V, de Azevedo MS. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. Front Microbiol 2017;8:800. [PMID: 28536562 DOI: 10.3389/fmicb.2017.00800] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
148 Goh HMS, Yong MHA, Chong KKL, Kline KA. Model systems for the study of Enterococcal colonization and infection. Virulence 2017;8:1525-62. [PMID: 28102784 DOI: 10.1080/21505594.2017.1279766] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
149 Zhao L, Ni Y, Su M, Li H, Dong F, Chen W, Wei R, Zhang L, Guiraud SP, Martin FP, Rajani C, Xie G, Jia W. High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization. Anal Chem 2017;89:5565-77. [PMID: 28437060 DOI: 10.1021/acs.analchem.7b00660] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
150 Robinson AM, Rahman AA, Miller S, Stavely R, Sakkal S, Nurgali K. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res Ther 2017;8:87. [PMID: 28420434 DOI: 10.1186/s13287-017-0540-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
151 Valatas V, Filidou E, Drygiannakis I, Kolios G. Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface. Ann Gastroenterol 2017;30:393-404. [PMID: 28655975 DOI: 10.20524/aog.2017.0146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
152 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
153 Andersen V, Hansen AK, Heitmann BL. Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease. Nutrients 2017;9:E286. [PMID: 28294972 DOI: 10.3390/nu9030286] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
154 Bao X, Feng Z, Yao J, Li T, Yin Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017;2017:6869259. [PMID: 28392631 DOI: 10.1155/2017/6869259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
155 Jia H, Hanate M, Aw W, Itoh H, Saito K, Kobayashi S, Hachimura S, Fukuda S, Tomita M, Hasebe Y, Kato H. Eggshell membrane powder ameliorates intestinal inflammation by facilitating the restitution of epithelial injury and alleviating microbial dysbiosis. Sci Rep 2017;7:43993. [PMID: 28272447 DOI: 10.1038/srep43993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
156 Shen NY, Bi JB, Zhang JY, Zhang SM, Gu JX, Qu K, Liu C. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression. World J Gastroenterol 2017; 23(8): 1375-1386 [PMID: 28293084 DOI: 10.3748/wjg.v23.i8.1375] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
157 de Morais Lima GR, Machado FDF, Périco LL, de Faria FM, Luiz-Ferreira A, Souza Brito ARM, Pellizzon CH, Hiruma-Lima CA, Tavares JF, Barbosa Filho JM, Batista LM. Anti-inflammatory intestinal activity of Combretum duarteanum Cambess. in trinitrobenzene sulfonic acid colitis model. World J Gastroenterol 2017; 23(8): 1353-1366 [PMID: 28293082 DOI: 10.3748/wjg.v23.i8.1353] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Atreya R, Neurath MF. Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease. Visc Med. 2017;33:82-88. [PMID: 28612022 DOI: 10.1159/000458006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
159 Date AA, Rais R, Babu T, Ortiz J, Kanvinde P, Thomas AG, Zimmermann SC, Gadiano AJ, Halpert G, Slusher BS, Ensign LM. Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease. J Control Release 2017;263:132-8. [PMID: 28159515 DOI: 10.1016/j.jconrel.2017.01.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
160 Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease. Front Immunol 2016;7:695. [PMID: 28119697 DOI: 10.3389/fimmu.2016.00695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
161 Silva FA, Rodrigues BL, Ayrizono ML, Leal RF. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:2097274. [PMID: 28070181 DOI: 10.1155/2016/2097274] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 11.5] [Reference Citation Analysis]
162 Jeon YD, Bang KS, Shin MK, Lee JH, Chang YN, Jin JS. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med 2016;16:459. [PMID: 27846836 DOI: 10.1186/s12906-016-1390-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
163 Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M. Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease. Dis Markers 2016;2016:6485343. [PMID: 27965521 DOI: 10.1155/2016/6485343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
164 Weigmann B, Neurath MF. Th9 cells in inflammatory bowel diseases. Semin Immunopathol. 2017;39:89-95. [PMID: 27837255 DOI: 10.1007/s00281-016-0603-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
165 Tanaka T, Oyama T, Sugie S, Shimizu M. Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis. Int J Mol Sci 2016;17:E1806. [PMID: 27801847 DOI: 10.3390/ijms17111806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
166 Paściak M, Górska S, Jawiarczyk N, Gamian A. Lactobacillus johnsonii glycolipids, their structure and immunoreactivity with sera from inflammatory bowel disease patients. Microb Biotechnol 2017;10:456-68. [PMID: 27766756 DOI: 10.1111/1751-7915.12424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
167 Chen YL, Chen YT, Lo CF, Hsieh CI, Chiu SY, Wu CY, Yeh YS, Hung SH, Cheng PH, Su YH, Jiang ST, Chin HJ, Su YC. Early Detection of T cell Transfer-induced Autoimmune Colitis by In Vivo Imaging System. Sci Rep 2016;6:35635. [PMID: 27762297 DOI: 10.1038/srep35635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
168 Yildiz G, Yildiz Y, Ulutas PA, Yaylali A, Ural M. Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats. Recent Pat Endocr Metab Immune Drug Discov 2015;9:134-40. [PMID: 26246013 DOI: 10.2174/1872214809666150806105737] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
169 Fischer A, Zundler S, Atreya R, Rath T, Voskens C, Hirschmann S, López-Posadas R, Watson A, Becker C, Schuler G, Neufert C, Atreya I, Neurath MF. Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo. Gut 2016;65:1642-64. [PMID: 26209553 DOI: 10.1136/gutjnl-2015-310022] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 15.3] [Reference Citation Analysis]
170 López-Posadas R, Neurath MF, Atreya I. Molecular pathways driving disease-specific alterations of intestinal epithelial cells. Cell Mol Life Sci 2017;74:803-26. [PMID: 27624395 DOI: 10.1007/s00018-016-2363-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
171 Yao J, Cao X, Zhang R, Li YX, Xu ZL, Zhang DG, Wang LS, Wang JY. Protective Effect of Baicalin Against Experimental Colitis via Suppression of Oxidant Stress and Apoptosis. Pharmacogn Mag. 2016;12:225-234. [PMID: 27601854 DOI: 10.4103/0973-1296.186342] [Cited by in Crossref: 25] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
172 Souza BM, Preisser TM, Pereira VB, Zurita-Turk M, de Castro CP, da Cunha VP, de Oliveira RP, Gomes-Santos AC, de Faria AM, Machado DC, Chatel JM, Azevedo VA, Langella P, Miyoshi A. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells. Microb Cell Fact 2016;15:150. [PMID: 27576902 DOI: 10.1186/s12934-016-0548-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
173 Yuan B, Zhou S, Lu Y, Liu J, Jin X, Wan H, Wang F. Changes in the Expression and Distribution of Claudins, Increased Epithelial Apoptosis, and a Mannan-Binding Lectin-Associated Immune Response Lead to Barrier Dysfunction in Dextran Sodium Sulfate-Induced Rat Colitis. Gut Liver. 2015;9:734-740. [PMID: 25717051 DOI: 10.5009/gnl14155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
174 Mezzasalma V, Manfrini E, Ferri E, Sandionigi A, La Ferla B, Schiano I, Michelotti A, Nobile V, Labra M, Di Gennaro P. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Res Int 2016;2016:4740907. [PMID: 27595104 DOI: 10.1155/2016/4740907] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
175 Rais R, Jiang W, Zhai H, Wozniak KM, Stathis M, Hollinger KR, Thomas AG, Rojas C, Vornov JJ, Marohn M, Li X, Slusher BS. FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight 2016;1:e88634. [PMID: 27536732 DOI: 10.1172/jci.insight.88634] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
176 Bek S, Nielsen JV, Bojesen AB, Franke A, Bank S, Vogel U, Andersen V. Systematic review: Genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases. Aliment Pharmacol Ther. 2016;44:554-567. [PMID: 27417569 DOI: 10.1111/apt.13736] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 11.3] [Reference Citation Analysis]
177 Punkenburg E, Vogler T, Büttner M, Amann K, Waldner M, Atreya R, Abendroth B, Mudter J, Merkel S, Gallmeier E, Rose-John S, Neurath MF, Hildner K. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer. Gut 2016;65:1139-50. [PMID: 25838550 DOI: 10.1136/gutjnl-2014-308227] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
178 Chen P, Bakke D, Kolodziej L, Lodolce J, Weber CR, Boone DL, Toback FG. Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2393-2402. [PMID: 26197453 DOI: 10.1097/mib.0000000000000499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
179 Shamran H, Singh NP, Zumbrun EE, Murphy A, Taub DD, Mishra MK, Price RL, Chatterjee S, Nagarkatti M, Nagarkatti PS, Singh UP. Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation. Brain Behav Immun 2017;59:10-20. [PMID: 27327245 DOI: 10.1016/j.bbi.2016.06.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
180 Al-Meghaiseeb ES, Al-Robayan AA, Al-Otaibi MM, Arfin M, Al-Asmari AK. Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease. J Inflamm Res 2016;9:133-40. [PMID: 27382325 DOI: 10.2147/JIR.S101225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
181 Zhang Q, Zhang C, Li X, Yu Y, Liang K, Shan X, Zhao K, Niu Q, Tian Z. WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease. Dis Markers 2016;2016:3547096. [PMID: 27403031 DOI: 10.1155/2016/3547096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
182 de Souza PR, Sales-Campos H, Basso PJ, Nardini V, Silva A, Banquieri F, Alves VB, Chica JE, Nomizo A, Cardoso CR. Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis. Mediators Inflamm 2016;2016:4936370. [PMID: 27403034 DOI: 10.1155/2016/4936370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
183 Atreya R, Bloom S, Scaldaferri F, Gerardi V, Admyre C, Karlsson Å, Knittel T, Kowalski J, Lukas M, Löfberg R, Nancey S, Petryka R, Rydzewska G, Schnabel R, Seidler U, Neurath MF, Hawkey C. Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis. J Crohns Colitis 2016;10:1294-302. [PMID: 27208386 DOI: 10.1093/ecco-jcc/jjw103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
184 Bergstrom K, Fu J, Johansson ME, Liu X, Gao N, Wu Q, Song J, McDaniel JM, McGee S, Chen W, Braun J, Hansson GC, Xia L. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol 2017;10:91-103. [PMID: 27143302 DOI: 10.1038/mi.2016.45] [Cited by in Crossref: 60] [Cited by in F6Publishing: 74] [Article Influence: 10.0] [Reference Citation Analysis]
185 Pérez-Bosque A, Miró L, Maijó M, Polo J, Campbell JM, Russell L, Crenshaw JD, Weaver E, Moretó M. Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate Has Immunomodulatory Effects on the Colon of Mice that Spontaneously Develop Colitis. PLoS One 2016;11:e0154823. [PMID: 27139220 DOI: 10.1371/journal.pone.0154823] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
186 Seong MA, Woo JK, Kang JH, Jang YS, Choi S, Jang YS, Lee TH, Jung KH, Kang DK, Hurh BS, Kim DE, Kim SY, Oh SH. Oral administration of fermented wild ginseng ameliorates DSS-induced acute colitis by inhibiting NF-κB signaling and protects intestinal epithelial barrier. BMB Rep 2015;48:419-25. [PMID: 25936779 DOI: 10.5483/bmbrep.2015.48.7.039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
187 Jeon YD, Kang SH, Bang KS, Chang YN, Lee JH, Jin JS. Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo. Molecules 2016;21:523. [PMID: 27110761 DOI: 10.3390/molecules21040523] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
188 Luo Y, Wu X, Ma Z, Tan W, Wang L, Na D, Zhang G, Yin A, Huang H, Xia D, Zhang Y, Shi X, Wang L. Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice. Cell Mol Immunol 2016;13:688-99. [PMID: 27086950 DOI: 10.1038/cmi.2016.16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
189 Chen F, Cao A, Yao S, Evans-Marin HL, Liu H, Wu W, Carlsen ED, Dann SM, Soong L, Sun J, Zhao Q, Cong Y. mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production. J Immunol 2016;196:4390-9. [PMID: 27067005 DOI: 10.4049/jimmunol.1501541] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
190 Vezza T, Rodríguez-nogales A, Algieri F, Utrilla M, Rodriguez-cabezas M, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients 2016;8:211. [DOI: 10.3390/nu8040211] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 18.8] [Reference Citation Analysis]
191 Chen Z, Yu K, Zhu F, Gorczynski R. Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis. PLoS One 2016;11:e0146681. [PMID: 26841120 DOI: 10.1371/journal.pone.0146681] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
192 Liu X, He H, Huang T, Lei Z, Liu F, An G, Wen T. Tanshinone IIA Protects against Dextran Sulfate Sodium- (DSS-) Induced Colitis in Mice by Modulation of Neutrophil Infiltration and Activation. Oxid Med Cell Longev 2016;2016:7916763. [PMID: 26881040 DOI: 10.1155/2016/7916763] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
193 Stavely R, Robinson AM, Miller S, Boyd R, Sakkal S, Nurgali K. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. Stem Cell Res Ther 2015;6:263. [PMID: 26718461 DOI: 10.1186/s13287-015-0254-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
194 Voronov E, Apte RN. IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer. Cancer Microenviron 2015;8:187-200. [PMID: 26686225 DOI: 10.1007/s12307-015-0177-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
195 Eder P, Łykowska-Szuber L, Krela-Kaźmierczak I, Stawczyk-Eder K, Iwanik K, Majewski P, Sterzyńska K, Zabel M, Linke K. Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease. Arch Med Sci 2015;11:1279-85. [PMID: 26788091 DOI: 10.5114/aoms.2015.54203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
196 Dharmaraj R, Jaber A, Arora R, Hagglund K, Lyons H. Seasonal variations in onset and exacerbation of inflammatory bowel diseases in children. BMC Res Notes 2015;8:696. [PMID: 26588900 DOI: 10.1186/s13104-015-1702-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
197 Neumann H, Neurath MF, Atreya R. Endoscopic Therapy in Inflammatory Bowel Diseases. Viszeralmedizin 2015;31:280-6. [PMID: 26557837 DOI: 10.1159/000435851] [Reference Citation Analysis]
198 Andersen V, Svenningsen K, Knudsen LA, Hansen AK, Holmskov U, Stensballe A, Vogel U. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. World J Gastroenterol 2015; 21(41): 11862-11876 [PMID: 26557010 DOI: 10.3748/wjg.v21.i41.11862] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
199 Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model. Int J Mol Sci 2015;16:26654-66. [PMID: 26561804 DOI: 10.3390/ijms161125985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
200 Tejón G, Manríquez V, De Calisto J, Flores-Santibáñez F, Hidalgo Y, Crisóstomo N, Fernández D, Sauma D, Mora JR, Bono MR, Rosemblatt M. Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation. Biomed Res Int 2015;2015:137893. [PMID: 26583087 DOI: 10.1155/2015/137893] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
201 Algieri F, Rodriguez-Nogales A, Rodriguez-Cabezas ME, Risco S, Ocete MA, Galvez J. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review. Mediators Inflamm. 2015;2015:179616. [PMID: 26576073 DOI: 10.1155/2015/179616] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
202 Senhaji N, Kojok K, Darif Y, Fadainia C, Zaid Y. The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update. Front Immunol 2015;6:529. [PMID: 26528290 DOI: 10.3389/fimmu.2015.00529] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
203 Cano-Garrido O, Seras-Franzoso J, Garcia-Fruitós E. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb Cell Fact 2015;14:137. [PMID: 26377321 DOI: 10.1186/s12934-015-0313-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 11.7] [Reference Citation Analysis]
204 Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 2015;36:1085-93. [PMID: 26354776 DOI: 10.1093/carcin/bgv123] [Cited by in Crossref: 148] [Cited by in F6Publishing: 180] [Article Influence: 21.1] [Reference Citation Analysis]
205 Riddle MS, Savarino SJ, Sanders JW. Gastrointestinal Infections in Deployed Forces in the Middle East Theater: An Historical 60 Year Perspective. Am J Trop Med Hyg 2015;93:912-7. [PMID: 26350450 DOI: 10.4269/ajtmh.15-0200] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
206 Rittling SR, Singh R. Osteopontin in Immune-mediated Diseases. J Dent Res 2015;94:1638-45. [PMID: 26341976 DOI: 10.1177/0022034515605270] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 10.6] [Reference Citation Analysis]
207 Le Loupp AG, Bach-Ngohou K, Bourreille A, Boudin H, Rolli-Derkinderen M, Denis MG, Neunlist M, Masson D. Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system. BMC Gastroenterol 2015;15:112. [PMID: 26338799 DOI: 10.1186/s12876-015-0338-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
208 Evans-Marin HL, Cao AT, Yao S, Chen F, He C, Liu H, Wu W, Gonzalez MG, Dann SM, Cong Y. Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development. PLoS One 2015;10:e0134100. [PMID: 26230654 DOI: 10.1371/journal.pone.0134100] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
209 Steinmann S, Scheibe K, Erlenbach-Wuensch K, Neufert C, Schneider-Stock R. Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review). Int J Oncol 2015;47:5-15. [PMID: 25963636 DOI: 10.3892/ijo.2015.2998] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
210 Sun H, Lou Y, Porturas T, Morrissey S, Luo G, Qi J, Ruan Q, Shi S, Chen YH. Exacerbated experimental colitis in TNFAIP8-deficient mice. J Immunol 2015;194:5736-42. [PMID: 25948814 DOI: 10.4049/jimmunol.1401986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
211 Almeida Cde S, Andrade-Oliveira V, Câmara NO, Jacysyn JF, Faquim-Mauro EL. Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice. PLoS One 2015;10:e0121427. [PMID: 25853847 DOI: 10.1371/journal.pone.0121427] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
212 Marjoram L, Bagnat M. Infection, Inflammation and Healing in Zebrafish: Intestinal Inflammation. Curr Pathobiol Rep 2015;3:147-53. [PMID: 26236567 DOI: 10.1007/s40139-015-0079-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
213 Gerlach K, McKenzie AN, Neurath MF, Weigmann B. IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue Barriers 2015;3:e983777. [PMID: 25838986 DOI: 10.4161/21688370.2014.983777] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
214 Hernandez M, Leichtle A, Pak K, Webster NJ, Wasserman SI, Ryan AF. The transcriptome of a complete episode of acute otitis media. BMC Genomics 2015;16:259. [PMID: 25888408 DOI: 10.1186/s12864-015-1475-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
215 Brandhorst G, Petrova DT, Weigand S, Eberle C, von Ahsen N, Schmitz J, Schultze FC, Raddatz D, Karaus M, Oellerich M, Walson PD. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients. World J Gastroenterol 2015; 21(11): 3325-3329 [PMID: 25805940 DOI: 10.3748/wjg.v21.i11.3325] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
216 Radulovic K, Niess JH. CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment? J Immunol Res 2015;2015:497056. [PMID: 25759842 DOI: 10.1155/2015/497056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
217 Liu HP, Cao AT, Feng T, Li Q, Zhang W, Yao S, Dann SM, Elson CO, Cong Y. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression. Eur J Immunol. 2015;45:1010-1018. [PMID: 25605286 DOI: 10.1002/eji.201444726] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
218 Zhang R, Gilbert S, Yao X, Vallance J, Steinbrecher K, Moriggl R, Zhang D, Eluri M, Chen H, Cao H, Shroyer N, Denson L, Han X. Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses. Pharmacol Res Perspect 2015;3:e00118. [PMID: 26038694 DOI: 10.1002/prp2.118] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
219 Grill JI, Neumann J, Hiltwein F, Kolligs FT, Schneider MR. Intestinal E-cadherin Deficiency Aggravates Dextran Sodium Sulfate-Induced Colitis. Dig Dis Sci. 2015;60:895-902. [PMID: 25634675 DOI: 10.1007/s10620-015-3551-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
220 Al-Meghaiseeb ES, Al-Otaibi MM, Al-Robayan A, Al-Amro R, Al-Malki AS, Arfin M, Al-Asmari AK. Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease. World J Gastroenterol 2015; 21(3): 897-904 [PMID: 25624723 DOI: 10.3748/wjg.v21.i3.897] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
221 Dreux N, del Mar Cendra M, Massier S, Darfeuille-Michaud A, Barnich N, Torrents E. Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection. Infect Immun 2015;83:1305-17. [PMID: 25605769 DOI: 10.1128/IAI.02772-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
222 Chung CY, Park YL, Kim N, Oh HH, Myung DS, Kim JS, Cho SB, Lee WS, Kim HS, Ahn BW, Joo YE. Rice prolamin extract ameliorates acute murine colitis by inhibiting nuclear factor-kappa B and modulating intestinal apoptosis and cell proliferation. Clin Exp Immunol 2014;178:537-47. [PMID: 25098704 DOI: 10.1111/cei.12431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
223 Živković M, Čadež N, Uroić K, Miljković M, Tolinački M, Doušova P, Kos B, Šušković J, Raspor P, Topisirović L, Golić N. Evaluation of probiotic potential of yeasts isolated from traditional cheeses manufactured in Serbia and Croatia. J Intercult Ethnopharmacol 2015;4:12-8. [PMID: 26401378 DOI: 10.5455/jice.20141128051842] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
224 Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA. Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis 2014;20:1037-48. [PMID: 24788216 DOI: 10.1097/MIB.0000000000000049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
225 Miyamoto J, Mizukure T, Park SB, Kishino S, Kimura I, Hirano K, Bergamo P, Rossi M, Suzuki T, Arita M, Ogawa J, Tanabe S. A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem. 2015;290:2902-2918. [PMID: 25505251 DOI: 10.1074/jbc.m114.610733] [Cited by in Crossref: 113] [Cited by in F6Publishing: 128] [Article Influence: 14.1] [Reference Citation Analysis]
226 Eder P, Lykowska-Szuber L, Stawczyk-Eder K, Krela-Kaźmierczak I, Linke K. Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases. Prz Gastroenterol 2014;9:275-9. [PMID: 25396001 DOI: 10.5114/pg.2014.46162] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
227 Alhouayek M, Bottemanne P, Subramanian KV, Lambert DM, Makriyannis A, Cani PD, Muccioli GG. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. FASEB J 2015;29:650-61. [PMID: 25384424 DOI: 10.1096/fj.14-255208] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 8.5] [Reference Citation Analysis]
228 Nidhi M, Kaur V, Hallan SS, Sharma S, Mishra N. Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review. Saudi Pharm J. 2016;24:458-472. [PMID: 27330377 DOI: 10.1016/j.jsps.2014.10.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
229 Alenghat T, Artis D. Epigenomic regulation of host-microbiota interactions. Trends Immunol. 2014;35:518-525. [PMID: 25443494 DOI: 10.1016/j.it.2014.09.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
230 Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself. 2010;1:299-309. [PMID: 21487504 DOI: 10.4161/self.1.4.13560] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 15.3] [Reference Citation Analysis]
231 Zhang HX, Wang ZT, Lu XX, Wang YG, Zhong J, Liu J. NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population. Inflamm Res. 2014;63:979-985. [PMID: 25297810 DOI: 10.1007/s00011-014-0774-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
232 Park JM, Han NY, Han YM, Chung MK, Lee HK, Ko KH, Kim EH, Hahm KB. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics? World J Gastroenterol 2014; 20(37): 13466-13476 [PMID: 25309077 DOI: 10.3748/wjg.v20.i37.13466] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
233 Huang LY, He Q, Liang SJ, Su YX, Xiong LX, Wu QQ, Wu QY, Tao J, Wang JP, Tang YB, Lv XF, Liu J, Guan YY, Pang RP, Zhou JG. ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice. Gut 2014;63:1587-95. [PMID: 24440986 DOI: 10.1136/gutjnl-2013-305168] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
234 Nishikawa K, Seo N, Torii M, Ma N, Muraoka D, Tawara I, Masuya M, Tanaka K, Takei Y, Shiku H, Katayama N, Kato T. Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation. PLoS One 2014;9:e108494. [PMID: 25254662 DOI: 10.1371/journal.pone.0108494] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
235 Nazareth N, Magro F, Silva J, Duro M, Gracio D, Coelho R, Appelberg R, Macedo G, Sarmento A. Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection. Clin Exp Immunol 2014;177:703-11. [PMID: 24816497 DOI: 10.1111/cei.12375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
236 Pellissier S, Dantzer C, Mondillon L, Trocme C, Gauchez AS, Ducros V, Mathieu N, Toussaint B, Fournier A, Canini F, Bonaz B. Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome. PLoS One 2014;9:e105328. [PMID: 25207649 DOI: 10.1371/journal.pone.0105328] [Cited by in Crossref: 94] [Cited by in F6Publishing: 103] [Article Influence: 11.8] [Reference Citation Analysis]
237 Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol 2014; 20(33): 11505-11524 [PMID: 25206258 DOI: 10.3748/wjg.v20.i33.11505] [Cited by in CrossRef: 113] [Cited by in F6Publishing: 92] [Article Influence: 14.1] [Reference Citation Analysis]
238 Mann ER, Li X. Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells. World J Gastroenterol 2014; 20(29): 9653-9664 [PMID: 25110405 DOI: 10.3748/wjg.v20.i29.9653] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
239 Luerce TD, Gomes-Santos AC, Rocha CS, Moreira TG, Cruz DN, Lemos L, Sousa AL, Pereira VB, de Azevedo M, Moraes K, Cara DC, LeBlanc JG, Azevedo V, Faria AMC, Miyoshi A. Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis. Gut Pathog 2014;6:33. [PMID: 25110521 DOI: 10.1186/1757-4749-6-33] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 7.1] [Reference Citation Analysis]
240 Guo B, Li Z. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Front Genet 2014;5:242. [PMID: 25120559 DOI: 10.3389/fgene.2014.00242] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
241 Hao Y, Nagase K, Hori K, Wang S, Kogure Y, Fukunaga K, Kashiwamura S, Yamamoto S, Nakamura S, Li J, Miwa H, Noguchi K, Dai Y. Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair. Evid Based Complement Alternat Med 2014;2014:569587. [PMID: 25120575 DOI: 10.1155/2014/569587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
242 Lou Y, Sun H, Morrissey S, Porturas T, Liu S, Hua X, Chen YH. Critical roles of TIPE2 protein in murine experimental colitis. J Immunol 2014;193:1064-70. [PMID: 24973456 DOI: 10.4049/jimmunol.1400415] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
243 Ślebioda TJ, Kmieć Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2014;2014:325129. [PMID: 25045210 DOI: 10.1155/2014/325129] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
244 Sturm EM, Radnai B, Jandl K, Stančić A, Parzmair GP, Högenauer C, Kump P, Wenzl H, Petritsch W, Pieber TR, Schuligoi R, Marsche G, Ferreirós N, Heinemann A, Schicho R. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. J Immunol 2014;193:827-39. [PMID: 24929001 DOI: 10.4049/jimmunol.1303484] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
245 Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, Lehr HA, Wirtz S, Vieth M, Waisman A. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-686. [PMID: 24908389 DOI: 10.1038/ni.2920] [Cited by in Crossref: 227] [Cited by in F6Publishing: 225] [Article Influence: 28.4] [Reference Citation Analysis]
246 Ye H, Wu Q, Zhu Y, Guo C, Zheng X. Ginsenoside Rh2 alleviates dextran sulfate sodium-induced colitis via augmenting TGFβ signaling. Mol Biol Rep 2014;41:5485-90. [PMID: 24893598 DOI: 10.1007/s11033-014-3422-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
247 Im E, Jung J, Pothoulakis C, Rhee SH. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice. Gastroenterology 2014;147:667-679.e10. [PMID: 24882466 DOI: 10.1053/j.gastro.2014.05.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
248 Caruso R, Marafini I, Franzè E, Stolfi C, Zorzi F, Monteleone I, Caprioli F, Colantoni A, Sarra M, Sedda S, Biancone L, Sileri P, Sica GS, MacDonald TT, Pallone F, Monteleone G. Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut. Mucosal Immunol 2014;7:1467-79. [PMID: 24850427 DOI: 10.1038/mi.2014.35] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
249 Bhol KC, Tracey DE, Lemos BR, Lyng GD, Erlich EC, Keane DM, Quesenberry MS, Holdorf AD, Schlehuber LD, Clark SA, Fox BS. AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2273-81. [PMID: 23949620 DOI: 10.1097/MIB.0b013e3182a11958] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
250 Karlsson F, Martinez NE, Gray L, Zhang S, Tsunoda I, Grisham MB. Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation. Inflamm Bowel Dis 2013;19:2282-94. [PMID: 23893082 DOI: 10.1097/MIB.0b013e31829c32dd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
251 Jakobsson T, Vedin LL, Hassan T, Venteclef N, Greco D, D'Amato M, Treuter E, Gustafsson JÅ, Steffensen KR. The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol 2014;7:1416-28. [PMID: 24803164 DOI: 10.1038/mi.2014.31] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
252 Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med (Maywood) 2014;239:1108-23. [PMID: 24781339 DOI: 10.1177/1535370214529388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
253 Halpert G, Eitan T, Voronov E, Apte RN, Rath-Wolfson L, Albeck M, Kalechman Y, Sredni B. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis. J Biol Chem 2014;289:17215-27. [PMID: 24764299 DOI: 10.1074/jbc.M113.536664] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
254 Bersudsky M, Luski L, Fishman D, White RM, Ziv-Sokolovskaya N, Dotan S, Rider P, Kaplanov I, Aychek T, Dinarello CA, Apte RN, Voronov E. Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice. Gut 2014;63:598-609. [PMID: 23793223 DOI: 10.1136/gutjnl-2012-303329] [Cited by in Crossref: 148] [Cited by in F6Publishing: 147] [Article Influence: 18.5] [Reference Citation Analysis]
255 Su L, Li N, Wu K, Wang X, Zhang M. Clinical significance of quantitative detection of serum tryptophan in patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(9): 1322-1327 [DOI: 10.11569/wcjd.v22.i9.1322] [Reference Citation Analysis]
256 Watanabe T, Asano N, Meng G, Yamashita K, Arai Y, Sakurai T, Kudo M, Fuss IJ, Kitani A, Shimosegawa T, Chiba T, Strober W. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal Immunol 2014;7:1312-25. [PMID: 24670424 DOI: 10.1038/mi.2014.19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
257 Fukuda K, Fujita Y. Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2014;14:49. [PMID: 24641276 DOI: 10.1186/1471-230x-14-49] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
258 Guo X, Jiang X, Xiao Y, Zhou T, Guo Y, Wang R, Zhao Z, Xiao H, Hou C, Ma L, Lin Y, Lang X, Feng J, Chen G, Shen B, Han G, Li Y. IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K. PLoS One 2014;9:e89714. [PMID: 24586980 DOI: 10.1371/journal.pone.0089714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
259 Atreya R, Neumann H, Neufert C, Waldner MJ, Billmeier U, Zopf Y, Willma M, App C, Münster T, Kessler H, Maas S, Gebhardt B, Heimke-Brinck R, Reuter E, Dörje F, Rau TT, Uter W, Wang TD, Kiesslich R, Vieth M, Hannappel E, Neurath MF. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat Med 2014;20:313-8. [PMID: 24562382 DOI: 10.1038/nm.3462] [Cited by in Crossref: 235] [Cited by in F6Publishing: 227] [Article Influence: 29.4] [Reference Citation Analysis]
260 Bouzid D, Gargouri B, Mansour RB, Amouri A, Tahri N, Lassoued S, Masmoudi H. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients. Saudi J Gastroenterol. 2013;19:131-135. [PMID: 23680711 DOI: 10.4103/1319-3767.111956] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
261 Krause P, Zahner SP, Kim G, Shaikh RB, Steinberg MW, Kronenberg M. The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice. Gastroenterology 2014;146:1752-62.e4. [PMID: 24560868 DOI: 10.1053/j.gastro.2014.02.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
262 Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014;146:1489-99. [PMID: 24560869 DOI: 10.1053/j.gastro.2014.02.009] [Cited by in Crossref: 896] [Cited by in F6Publishing: 952] [Article Influence: 112.0] [Reference Citation Analysis]
263 Cavalcanti E, Vadrucci E, Delvecchio FR, Addabbo F, Bettini S, Liou R, Monsurrò V, Huang AY, Pizarro TT, Santino A, Chieppa M. Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation. PLoS One 2014;9:e88898. [PMID: 24558444 DOI: 10.1371/journal.pone.0088898] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
264 Storr M, Vogel HJ, Schicho R. Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol. 2013;29:378-383. [PMID: 23624676 DOI: 10.1097/mog.0b013e328361f488] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
265 Li TT, Zhang JF, Fei SJ, Zhu SP, Zhu JZ, Qiao X, Liu ZB. Glutamate microinjection into the hypothalamic paraventricular nucleus attenuates ulcerative colitis in rats. Acta Pharmacol Sin 2014;35:185-94. [PMID: 24362327 DOI: 10.1038/aps.2013.140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
266 Brazil JC, Louis NA, Parkos CA. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1556-65. [PMID: 23598816 DOI: 10.1097/MIB.0b013e318281f54e] [Cited by in Crossref: 84] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
267 Santos Rocha C, Gomes-Santos AC, Garcias Moreira T, de Azevedo M, Diniz Luerce T, Mariadassou M, Longaray Delamare AP, Langella P, Maguin E, Azevedo V, Caetano de Faria AM, Miyoshi A, van de Guchte M. Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii. PLoS One 2014;9:e85923. [PMID: 24465791 DOI: 10.1371/journal.pone.0085923] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
268 Eckhardt J, Kreiser S, Döbbeler M, Nicolette C, DeBenedette MA, Tcherepanova IY, Ostalecki C, Pommer AJ, Becker C, Günther C. Soluble CD83 ameliorates experimental colitis in mice. Mucosal Immunol. 2014;7:1006-1018. [PMID: 24424524 DOI: 10.1038/mi.2013.119] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
269 Andrade TG, Fogaça HS, Elia CC, Pitrowsky MT, Souza HS. Crohn's disease activity assessed by Doppler sonography: the role of aortic flow parameters. Clinics (Sao Paulo) 2013;68:457-62. [PMID: 23778348 DOI: 10.6061/clinics/2013(04)04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
270 Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013;24:631-644. [PMID: 24229710 DOI: 10.1016/j.ccr.2013.10.009] [Cited by in Crossref: 268] [Cited by in F6Publishing: 260] [Article Influence: 33.5] [Reference Citation Analysis]
271 Dawiskiba T, Deja S, Mulak A, Ząbek A, Jawień E, Pawełka D, Banasik M, Mastalerz-Migas A, Balcerzak W, Kaliszewski K, Skóra J, Barć P, Korta K, Pormańczuk K, Szyber P, Litarski A, Młynarz P. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol 2014; 20(1): 163-174 [PMID: 24415869 DOI: 10.3748/wjg.v20.i1.163] [Cited by in CrossRef: 116] [Cited by in F6Publishing: 109] [Article Influence: 14.5] [Reference Citation Analysis]
272 Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20(1): 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6] [Cited by in CrossRef: 311] [Cited by in F6Publishing: 289] [Article Influence: 38.9] [Reference Citation Analysis]
273 Bellavista E, Santoro A, Galimberti D, Comi C, Luciani F, Mishto M. Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis. Autoimmune Dis 2014;2014:739705. [PMID: 24523959 DOI: 10.1155/2014/739705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
274 Petreska Ivanovska T, Jurhar Pavlova M, Mladenovska K, Petrushevska-tozi L. Probiotics, prebiotics, synbiotics in prevention and treatment of inflammatory bowel diseases. Maced Pharm Bull 2014;60:3-19. [DOI: 10.33320/maced.pharm.bull.2014.60.02.001] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
275 Fan HY, Zhang ZL, Liu K, Yang MY, Lv WH, Che X, Xu H, Song WW. Effectiveness of a hydroxynaphthoquinone fraction from Arnebia euchroma in rats with experimental colitis. World J Gastroenterol 2013; 19(48): 9318-9327 [PMID: 24409058 DOI: 10.3748/wjg.v19.i48.9318] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
276 Koido S, Ohkusa T, Saito H, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Seasonal variations in the onset of ulcerative colitis in Japan. World J Gastroenterol 2013; 19(47): 9063-9068 [PMID: 24379632 DOI: 10.3748/wjg.v19.i47.9063] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
277 Ono K, Nimura S, Nishinakagawa T, Hideshima Y, Enjyoji M, Nabeshima K, Nakashima M. Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice. Exp Ther Med 2014;7:573-8. [PMID: 24520247 DOI: 10.3892/etm.2013.1456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
278 Koboziev I, Reinoso Webb C, Furr KL, Grisham MB. Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med. 2014;68:122-133. [PMID: 24275541 DOI: 10.1016/j.freeradbiomed.2013.11.008] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 10.6] [Reference Citation Analysis]
279 Kaneko A, Kono T, Miura N, Tsuchiya N, Yamamoto M. Preventive Effect of TU-100 on a Type-2 Model of Colitis in Mice: Possible Involvement of Enhancing Adrenomedullin in Intestinal Epithelial Cells. Gastroenterol Res Pract. 2013;2013:384057. [PMID: 24348533 DOI: 10.1155/2013/384057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
280 Preter VD, Verbeke K. Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther 2013; 4(4): 97-107 [PMID: 24199025 DOI: 10.4292/wjgpt.v4.i4.97] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
281 Alenghat T, Osborne LC, Saenz SA, Kobuley D, Ziegler CG, Mullican SE, Choi I, Grunberg S, Sinha R, Wynosky-Dolfi M, Snyder A, Giacomin PR, Joyce KL, Hoang TB, Bewtra M, Brodsky IE, Sonnenberg GF, Bushman FD, Won KJ, Lazar MA, Artis D. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 2013;504:153-7. [PMID: 24185009 DOI: 10.1038/nature12687] [Cited by in Crossref: 133] [Cited by in F6Publishing: 126] [Article Influence: 14.8] [Reference Citation Analysis]
282 Yuan Y, Xu W, He X, Liu H, Cao S, Qi X, Huang K, Luo Y. Effects of genetically modified T2A-1 rice on the GI health of rats after 90-day supplement. Sci Rep 2013;3:1962. [PMID: 23752350 DOI: 10.1038/srep01962] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
283 Lee HS, Jang MS, Kim JH, Hong CP, Lee EJ, Jeun EJ, Kim C, Kim EK, Ahn KS, Yang BG, Ahn KS, Jang YP, Ahn KS, Kim YM, Jang MH. Ulmus davidiana var. japonica Nakai upregulates eosinophils and suppresses Th1 and Th17 cells in the small intestine. PLoS One 2013;8:e76716. [PMID: 24116141 DOI: 10.1371/journal.pone.0076716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
284 Kerkar SP. "Model t" cells: a time-tested vehicle for gene therapy. Front Immunol 2013;4:304. [PMID: 24098300 DOI: 10.3389/fimmu.2013.00304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
285 Liu Z, Cao AT, Cong Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol. 2013;23:543-552. [PMID: 24071482 DOI: 10.1016/j.semcancer.2013.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
286 Yu Q, Zhu S, Zhou R, Yi F, Bing Y, Huang S, Wang Z, Wang C, Xia B. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. PLoS One 2013;8:e73757. [PMID: 24066068 DOI: 10.1371/journal.pone.0073757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
287 Iraha A, Chinen H, Hokama A, Yonashiro T, Kinjo T, Kishimoto K, Nakamoto M, Hirata T, Kinjo N, Higa F, Tateyama M, Kinjo F, Fujita J. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World J Gastroenterol 2013; 19(33): 5500-5507 [PMID: 24023493 DOI: 10.3748/wjg.v19.i33.5500] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
288 Devine AA, Gonzalez A, Speck KE, Knight R, Helmrath M, Lund PK, Azcarate-Peril MA. Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon. PLoS One. 2013;8:e73140. [PMID: 24015295 DOI: 10.1371/journal.pone.0073140] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
289 Strober W. Impact of the gut microbiome on mucosal inflammation. Trends Immunol 2013;34:423-30. [PMID: 23957963 DOI: 10.1016/j.it.2013.07.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
290 Gauss A, Buchholz I, Zahn A, Schmitz G, Stremmel W, Fuellekrug J, Ehehalt R. Flotillin-2 expression in the human gut: from a cell model to human tissue in health and inflammatory bowel diseases. Int J Med Sci 2013;10:1259-70. [PMID: 23983584 DOI: 10.7150/ijms.6358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
291 Bellavia M, Tomasello G, Romeo M, Damiani P, Lo Monte AI, Lozio L, Campanella C, Marino Gammazza A, Rappa F, Zummo G. Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol. 2013;202:393-406. [PMID: 23864544 DOI: 10.1007/s00430-013-0305-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
292 Mann ER, You J, Horneffer-van der Sluis V, Bernardo D, Omar Al-Hassi H, Landy J, Peake ST, Thomas LV, Tee CT, Lee GH. Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain Lactobacillus casei Shirota. Mediators Inflamm. 2013;2013:573576. [PMID: 23970814 DOI: 10.1155/2013/573576] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
293 Günther C, Neumann H, Neurath MF, Becker C. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 2013;62:1062-71. [PMID: 22689519 DOI: 10.1136/gutjnl-2011-301364] [Cited by in Crossref: 242] [Cited by in F6Publishing: 239] [Article Influence: 26.9] [Reference Citation Analysis]
294 Nolte T, Zadeh-Khorasani M, Safarov O, Rueff F, Gülberg V, Herbach N, Wollenberg A, Mueller T, Siebeck M, Wolf E, Gropp R. Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells. Clin Exp Immunol 2013;172:349-62. [PMID: 23574330 DOI: 10.1111/cei.12057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
295 Kriegel C, Attarwala H, Amiji M. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract. Adv Drug Deliv Rev 2013;65:891-901. [PMID: 23220324 DOI: 10.1016/j.addr.2012.11.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
296 Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One. 2013;8:e62144. [PMID: 23634226 DOI: 10.1371/journal.pone.0062144] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
297 Neufert C, Becker C, Türeci Ö, Waldner MJ, Backert I, Floh K, Atreya I, Leppkes M, Jefremow A, Vieth M. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J Clin Invest. 2013;123:1428-1443. [PMID: 23549083 DOI: 10.1172/jci63748] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
298 Stojancevic M, Stankov K, Mikov M. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease. Can J Gastroenterol 2012;26:631-7. [PMID: 22993736 DOI: 10.1155/2012/538452] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
299 Brenna Ø, Furnes MW, Drozdov I, van Beelen Granlund A, Flatberg A, Sandvik AK, Zwiggelaar RT, Mårvik R, Nordrum IS, Kidd M, Gustafsson BI. Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD. PLoS One 2013;8:e54543. [PMID: 23382912 DOI: 10.1371/journal.pone.0054543] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
300 Maltby R, Leatham-Jensen MP, Gibson T, Cohen PS, Conway T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157: H7 in the mouse intestine. PLoS One. 2013;8:e53957. [PMID: 23349773 DOI: 10.1371/journal.pone.0053957] [Cited by in Crossref: 136] [Cited by in F6Publishing: 126] [Article Influence: 15.1] [Reference Citation Analysis]
301 Zorzi F, Monteleone I, Sarra M, Calabrese E, Marafini I, Cretella M, Sedda S, Biancone L, Pallone F, Monteleone G. Distinct profiles of effector cytokines mark the different phases of Crohn’s disease. PLoS One. 2013;8:e54562. [PMID: 23349929 DOI: 10.1371/journal.pone.0054562] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
302 Myung D, Park Y, Joo S, Myung E, Chung C, Park H, Kim J, Cho S, Lee W, Kim H, Joo Y. Epigallocatechin-3-gallate Inhibits the Expression of Adhesion Molecules by Blocking Nuclear Factor Kappa B Signaling in Intestinal Epithelial Cells. Intest Res 2013;11:261. [DOI: 10.5217/ir.2013.11.4.261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
303 Sun X, Chalmers L, Fu X, Zhao M. A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing. Adv Wound Care (New Rochelle) 2012;1:231-7. [PMID: 24527311 DOI: 10.1089/wound.2011.0334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
304 Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229-244. [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6] [Cited by in Crossref: 291] [Cited by in F6Publishing: 310] [Article Influence: 29.1] [Reference Citation Analysis]
305 Monteleone G, Caruso R, Pallone F. Role of Smad7 in inflammatory bowel diseases. World J Gastroenterol 2012; 18(40): 5664-5668 [PMID: 23155305 DOI: 10.3748/wjg.v18.i40.5664] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
306 Chassaing B, Darfeuille-Michaud A. The σE pathway is involved in biofilm formation by Crohn’s disease-associated adherent-invasive Escherichia coli. J Bacteriol. 2013;195:76-84. [PMID: 23104802 DOI: 10.1128/jb.01079-12] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
307 Bernard JK, McCann SP, Bhardwaj V, Washington MK, Frey MR. Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. J Biol Chem 2012;287:39850-8. [PMID: 23033483 DOI: 10.1074/jbc.M112.400846] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
308 Feng T, Elson CO, Cong Y. Microbiota: dual-faceted player in experimental colitis. Gut Microbes 2010;1:388-91. [PMID: 21468221 DOI: 10.4161/gmic.1.6.13727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
309 Aldini R, Budriesi R, Roda G, Micucci M, Ioan P, D'Errico-Grigioni A, Sartini A, Guidetti E, Marocchi M, Cevenini M, Rosini F, Montagnani M, Chiarini A, Mazzella G. Curcuma longa extract exerts a myorelaxant effect on the ileum and colon in a mouse experimental colitis model, independent of the anti-inflammatory effect. PLoS One 2012;7:e44650. [PMID: 22984538 DOI: 10.1371/journal.pone.0044650] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
310 Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC; MTN Biomedical Sciences Working Group., HPTN 035 Protocol Team. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis 2012;206:1931-5. [PMID: 22966121 DOI: 10.1093/infdis/jis555] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
311 Pacheco RG, Esposito CC, Müller LC, Castelo-Branco MT, Quintella LP, Chagas VLA, de Souza HSP, Schanaider A. Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis. World J Gastroenterol 2012; 18(32): 4278-4287 [PMID: 22969190 DOI: 10.3748/wjg.v18.i32.4278] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
312 Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608. [PMID: 22907164 DOI: 10.1038/nrgastro.2012.152.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608. [PMID: 22907164 DOI: 10.1038/nrgastro.2012.152] [Cited by in Crossref: 739] [Cited by in F6Publishing: 692] [Article Influence: 73.9] [Reference Citation Analysis]
314 Watanabe T, Yamashita K, Sakurai T, Kudo M, Shiokawa M, Uza N, Kodama Y, Uchida K, Okazaki K, Chiba T. Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J Gastroenterol. 2013;48:247-253. [PMID: 22744834 DOI: 10.1007/s00535-012-0626-8] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 8.0] [Reference Citation Analysis]
315 Zhang XJ, Leung FP, Hsiao WW, Tan S, Li S, Xu HX, Sung JJ, Bian ZX. Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2012; 18(23): 2914-2928 [PMID: 22736915 DOI: 10.3748/wjg.v18.i23.2914] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
316 Ettreiki C, Gadonna-Widehem P, Mangin I, Coëffier M, Delayre-Orthez C, Anton PM. Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents. World J Gastroenterol 2012; 18(21): 2619-2629 [PMID: 22690070 DOI: 10.3748/wjg.v18.i21.2619] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
317 Suárez J, Romero-Zerbo Y, Márquez L, Rivera P, Iglesias M, Bermúdez-Silva FJ, Andreu M, Rodríguez de Fonseca F. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids. PLoS One 2012;7:e37729. [PMID: 22662201 DOI: 10.1371/journal.pone.0037729] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
318 Singh UP, Singh NP, Busbee B, Guan H, Singh B, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS. Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol. 2012;31:66-84. [PMID: 22251008 DOI: 10.3109/08830185.2011.642909] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
319 Saldua MA, Olsovsky CA, Callaway ES, Chapkin RS, Maitland KC. Imaging inflammation in mouse colon using a rapid stage-scanning confocal fluorescence microscope. J Biomed Opt 2012;17:016006. [PMID: 22352656 DOI: 10.1117/1.JBO.17.1.016006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
320 Hotte NS, Salim SY, Tso RH, Albert EJ, Bach P, Walker J, Dieleman LA, Fedorak RN, Madsen KL. Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA. PLoS One. 2012;7:e37932. [PMID: 22649567 DOI: 10.1371/journal.pone.0037932] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
321 Zhou FX, Chen L, Liu XW, Ouyang CH, Wu XP, Wang XH, Wang CL, Lu FG. Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses. World J Gastroenterol 2012; 18(19): 2344-2356 [PMID: 22654425 DOI: 10.3748/wjg.v18.i19.2344] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
322 Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res 2012;11:3344-57. [PMID: 22574726 DOI: 10.1021/pr300139q] [Cited by in Crossref: 145] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
323 Zhao QJ, Yu YB, Zuo XL, Dong YY, Li YQ. Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing. Mol Med. 2012;18:497-506. [PMID: 22204000 DOI: 10.2119/molmed.2011.00369] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
324 Samanta AK, Torok VA, Percy NJ, Abimosleh SM, Howarth GS. Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. J Microbiol. 2012;50:218-225. [PMID: 22538649 DOI: 10.1007/s12275-012-1362-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
325 Joo SY, Song YA, Park YL, Myung E, Chung CY, Park KJ, Cho SB, Lee WS, Kim HS, Rew JS, Kim NS, Joo YE. Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages. Gut Liver 2012;6:188-96. [PMID: 22570747 DOI: 10.5009/gnl.2012.6.2.188] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
326 Koboziev I, Karlsson F, Ostanin DV, Gray L, Davidson M, Zhang S, Grisham MB. Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis. Inflamm Bowel Dis 2012;18:2360-70. [PMID: 22488891 DOI: 10.1002/ibd.22947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
327 Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135:112-124. [PMID: 22044352 DOI: 10.1111/j.1365-2567.2011.03522.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 121] [Article Influence: 13.4] [Reference Citation Analysis]
328 Xie Y, Luo Z, Li Z, Deng M, Liu H, Zhu B, Ruan B, Li L. Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation. Microb Ecol. 2012;64:546-554. [PMID: 22430504 DOI: 10.1007/s00248-012-0030-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
329 Alt C, Lam JS, Harrison MT, Kershaw KM, Samuelsson S, Toll L, D'Andrea A. Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis. Eur J Pharmacol 2012;683:285-93. [PMID: 22449384 DOI: 10.1016/j.ejphar.2012.03.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
330 Zadeh M, Khan MW, Goh YJ, Selle K, Owen JL, Klaenhammer T, Mohamadzadeh M. Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) 2012;9:7. [PMID: 22423982 DOI: 10.1186/1476-9255-9-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
331 Kayama H, Ueda Y, Sawa Y, Jeon SG, Ma JS, Okumura R, Kubo A, Ishii M, Okazaki T, Murakami M, Yamamoto M, Yagita H, Takeda K. Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proc Natl Acad Sci U S A 2012;109:5010-5. [PMID: 22403066 DOI: 10.1073/pnas.1114931109] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
332 Kesselring R, Fichtner-Feigl S. Immune responses triggering colitis and colitis-associated carcinoma. Langenbecks Arch Surg 2012;397:527-33. [PMID: 22382701 DOI: 10.1007/s00423-012-0927-7] [Reference Citation Analysis]
333 Schoeb TR, Bullard DC. Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:1558-65. [PMID: 22294506 DOI: 10.1002/ibd.22892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
334 Smith P, Siddharth J, Pearson R, Holway N, Shaxted M, Butler M, Clark N, Jamontt J, Watson RP, Sanmugalingam D, Parkinson SJ. Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota. PLoS One. 2012;7:e30273. [PMID: 22272321 DOI: 10.1371/journal.pone.0030273] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
335 Kim YS, Lee MH, Ju AS, Rhee KJ. Th17 responses are not induced in dextran sodium sulfate model of acute colitis. Immune Netw. 2011;11:416-419. [PMID: 22346784 DOI: 10.4110/in.2011.11.6.416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
336 Singh N, Shirdel EA, Waldron L, Zhang RH, Jurisica I, Comelli EM. The murine caecal microRNA signature depends on the presence of the endogenous microbiota. Int J Biol Sci. 2012;8:171-186. [PMID: 22211115 DOI: 10.7150/ijbs.8.171] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 6.6] [Reference Citation Analysis]
337 Molloy MJ, Bouladoux N, Belkaid Y. Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol 2012;24:58-66. [PMID: 22178452 DOI: 10.1016/j.smim.2011.11.008] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 9.3] [Reference Citation Analysis]
338 Yan F, Wang L, Shi Y, Cao H, Liu L, Washington MK, Chaturvedi R, Israel DA, Cao H, Wang B. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G504-G514. [PMID: 22173918 DOI: 10.1152/ajpgi.00312.2011] [Cited by in Crossref: 120] [Cited by in F6Publishing: 118] [Article Influence: 10.9] [Reference Citation Analysis]
339 Murphy CT, Nally K, Shanahan F, Melgar S. Shining a light on intestinal traffic. Clin Dev Immunol 2012;2012:808157. [PMID: 22162719 DOI: 10.1155/2012/808157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
340 Friedman DJ, Turka LA, Robson SC. There's a goat behind door number 3: from Monty Hall to medicine. J Clin Invest 2011;121:3819-21. [PMID: 21968106 DOI: 10.1172/JCI60003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
341 Monteleone I, Pallone F, Monteleone G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med 2011;9:122. [PMID: 22082127 DOI: 10.1186/1741-7015-9-122] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
342 Xue X, Feng T, Yao S, Wolf KJ, Liu CG, Liu X, Elson CO, Cong Y. Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol. 2011;187:5879-5886. [PMID: 22068236 DOI: 10.4049/jimmunol.1100535] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 9.1] [Reference Citation Analysis]
343 Chen GY, Núñez G. Inflammasomes in Intestinal Inflammation and Cancer. Gastroenterology 2011;141:1986-99. [DOI: 10.1053/j.gastro.2011.10.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 9.5] [Reference Citation Analysis]
344 Song YA, Park YL, Kim KY, Chung CY, Lee GH, Cho DH, Ki HS, Park KJ, Cho SB, Lee WS, Kim N, Ahn BW, Joo YE. Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis. BMC Complement Altern Med 2011;11:91. [PMID: 21989142 DOI: 10.1186/1472-6882-11-91] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
345 Li RD, Han GX, Tao KX. Role of interaction between Th17 cells and commensal microbiota in the pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2011; 19(28): 2907-2912 [DOI: 10.11569/wcjd.v19.i28.2907] [Reference Citation Analysis]
346 Sibtain AM, Spady D, El-Matary W. Immune-related disorders in families of children with inflammatory bowel disease--a prospective cohort study. Ital J Pediatr 2011;37:49. [PMID: 21970749 DOI: 10.1186/1824-7288-37-49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
347 Li XD, Chiu YH, Ismail AS, Behrendt CL, Wight-Carter M, Hooper LV, Chen ZJ. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc Natl Acad Sci U S A 2011;108:17390-5. [PMID: 21960441 DOI: 10.1073/pnas.1107114108] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
348 Sun S, Wang X, Wu X, Zhao Y, Wang F, Liu X, Song Y, Wu Z, Liu M. Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease. Parasit Vectors 2011;4:186. [PMID: 21943110 DOI: 10.1186/1756-3305-4-186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
349 Schicho R, Storr M. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol 2011;25:377-83. [PMID: 21876860 DOI: 10.1155/2011/953975] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
350 Günther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477:335-339. [PMID: 21921917 DOI: 10.1038/nature10400] [Cited by in Crossref: 546] [Cited by in F6Publishing: 630] [Article Influence: 49.6] [Reference Citation Analysis]
351 Kim S, Joo YE. Theaflavin Inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 Expression in Bone Marrow-Derived Macrophages Through the Blockade of NF-κB and MAPK Signaling Pathways. Chonnam Med J 2011;47:104-10. [PMID: 22111069 DOI: 10.4068/cmj.2011.47.2.104] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
352 Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernández-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011;477:330-334. [PMID: 21804564 DOI: 10.1038/nature10273] [Cited by in Crossref: 410] [Cited by in F6Publishing: 496] [Article Influence: 37.3] [Reference Citation Analysis]
353 Singh UP, Singh NP, Singh B, Hofseth LJ, Taub DD, Price RL, Nagarkatti M, Nagarkatti PS. Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice. Brain Behav Immun. 2012;26:72-82. [PMID: 21807089 DOI: 10.1016/j.bbi.2011.07.236] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
354 Hasegawa S, Ichiyama T, Sonaka I, Ohsaki A, Hirano R, Haneda Y, Fukano R, Hara M, Furukawa S. Amino acids exhibit anti-inflammatory effects in human monocytic leukemia cell line, THP-1 cells. Inflamm Res 2011;60:1013-9. [PMID: 21785859 DOI: 10.1007/s00011-011-0362-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
355 Glazer RI, Yuan H, Xie Z, Yin Y. PPARgamma and PPARdelta as Modulators of Neoplasia and Cell Fate. PPAR Res 2008;2008:247379. [PMID: 18566686 DOI: 10.1155/2008/247379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
356 Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn’s disease. Mucosal Immunol. 2011;4:484-495. [PMID: 21750585 DOI: 10.1038/mi.2011.29] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 9.6] [Reference Citation Analysis]
357 Queiroz KC, Van 't Veer C, Van Den Berg Y, Duitman J, Versteeg HH, Aberson HL, Groot AP, Verstege MI, Roelofs JJ, Te Velde AA, Spek CA. Tissue factor-dependent chemokine production aggravates experimental colitis. Mol Med 2011;17:1119-26. [PMID: 21717035 DOI: 10.2119/molmed.2011.00138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
358 Takai A, Marusawa H, Chiba T. Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis. Cancers (Basel) 2011;3:2750-66. [PMID: 24212831 DOI: 10.3390/cancers3022750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
359 Li Q, Zhang Q, Wang C, Tang C, Zhang Y, Li N, Li J. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoS One 2011;6:e20460. [PMID: 21698145 DOI: 10.1371/journal.pone.0020460] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
360 Vazeille E, Bringer MA, Gardarin A, Chambon C, Becker-Pauly C, Pender SL, Jakob C, Müller S, Lottaz D, Darfeuille-Michaud A. Role of meprins to protect ileal mucosa of Crohn’s disease patients from colonization by adherent-invasive E. coli. PLoS One. 2011;6:e21199. [PMID: 21698174 DOI: 10.1371/journal.pone.0021199] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
361 Raso T, Crivellaro S, Chirillo MG, Pais P, Gaia E, Savoia D. Analysis of Escherichia coli isolated from patients affected by Crohn's disease. Curr Microbiol. 2011;63:131-137. [PMID: 21626145 DOI: 10.1007/s00284-011-9947-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
362 Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM Jr, Wilson KT, Polk DB. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011;121:2242-2253. [PMID: 21606592 DOI: 10.1172/jci44031] [Cited by in Crossref: 209] [Cited by in F6Publishing: 211] [Article Influence: 19.0] [Reference Citation Analysis]
363 Smith AM, Qualls JE, O'Brien K, Balouzian L, Johnson PF, Schultz-Cherry S, Smale ST, Murray PJ. A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3. J Biol Chem 2011;286:23582-90. [PMID: 21566115 DOI: 10.1074/jbc.M111.249235] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
364 Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis. 2011;17:289-297. [PMID: 20564535 DOI: 10.1002/ibd.21366] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
365 Schiechl G, Bauer B, Fuss I, Lang SA, Moser C, Ruemmele P, Rose-John S, Neurath MF, Geissler EK, Schlitt HJ, Strober W, Fichtner-Feigl S. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. J Clin Invest 2011;121:1692-708. [PMID: 21519141 DOI: 10.1172/JCI42540] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
366 Lohr K, Sardana H, Lee S, Wu F, Huso DL, Hamad AR, Chakravarti S. Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis. Inflamm Bowel Dis 2012;18:143-51. [PMID: 21484968 DOI: 10.1002/ibd.21713] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
367 Stappenbeck TS, Rioux JD, Mizoguchi A, Saitoh T, Huett A, Darfeuille-Michaud A, Wileman T, Mizushima N, Carding S, Akira S, Parkes M, Xavier RJ. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy 2011;7:355-74. [PMID: 20729636 DOI: 10.4161/auto.7.2.13074] [Cited by in F6Publishing: 48] [Reference Citation Analysis]
368 Stappenbeck TS, Rioux JD, Mizoguchi A, Saitoh T, Huett A, Darfeuille-Michaud A, Wileman T, Mizushima N, Carding S, Akira S, Parkes M, Xavier RJ. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy 2011;7:355-74. [PMID: 20729636 DOI: 10.4161/auto.7.2.13074] [Cited by in Crossref: 67] [Cited by in F6Publishing: 18] [Article Influence: 6.1] [Reference Citation Analysis]
369 Kriegel C, Amiji MM. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2011;2:e2. [PMID: 23237848 DOI: 10.1038/ctg.2011.1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
370 Sidhu M, Cotoner CA, Guleng B, Arihiro S, Chang S, Duncan KW, Ajami AM, Chau M, Reinecker HC. Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation. Inflamm Bowel Dis 2011;17:2416-26. [PMID: 21438094 DOI: 10.1002/ibd.21646] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
371 Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;121:1657-1666. [PMID: 21383503 DOI: 10.1172/jci45538] [Cited by in Crossref: 206] [Cited by in F6Publishing: 216] [Article Influence: 18.7] [Reference Citation Analysis]
372 Furumatsu K, Nishiumi S, Kawano Y, Ooi M, Yoshie T, Shiomi Y, Kutsumi H, Ashida H, Fujii-Kuriyama Y, Azuma T. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci. 2011;56:2532-2544. [PMID: 21374063 DOI: 10.1007/s10620-011-1643-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 9.4] [Reference Citation Analysis]
373 Strober W. Adherent-invasive E. coli in Crohn disease: bacterial "agent provocateur". J Clin Invest 2011;121:841-4. [PMID: 21339637 DOI: 10.1172/JCI46333] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
374 Chassaing B, Rolhion N, de Vallée A, Salim SY, Prorok-Hamon M, Neut C, Campbell BJ, Söderholm JD, Hugot JP, Colombel JF. Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer’s patches via long polar fimbriae. J Clin Invest. 2011;121:966-975. [PMID: 21339647 DOI: 10.1172/jci44632] [Cited by in Crossref: 168] [Cited by in F6Publishing: 174] [Article Influence: 15.3] [Reference Citation Analysis]
375 Koboziev I, Karlsson F, Zhang S, Grisham MB. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 2011;17:1229-45. [PMID: 21312318 DOI: 10.1002/ibd.21557] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
376 Hundorfean G, Neurath MF, Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010;14:2393-403. [PMID: 19878366 DOI: 10.1111/j.1582-4934.2009.00959.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
377 Han X, Mann E, Gilbert S, Guan Y, Steinbrecher KA, Montrose MH, Cohen MB. Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier. PLoS One. 2011;6:e16139. [PMID: 21305056 DOI: 10.1371/journal.pone.0016139] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
378 Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. World J Gastroenterol 2011; 17(2): 197-206 [PMID: 21245992 DOI: 10.3748/wjg.v17.i2.197] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
379 Moussata D, Goetz M, Gloeckner A, Kerner M, Campbell B, Hoffman A, Biesterfeld S, Flourie B, Saurin JC, Galle PR, Neurath MF, Watson AJ, Kiesslich R. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut 2011;60:26-33. [PMID: 20980342 DOI: 10.1136/gut.2010.213264] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
380 Song YA, Park YL, Yoon SH, Kim KY, Cho SB, Lee WS, Chung IJ, Joo YE. Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells. Inflamm Res 2011;60:493-500. [PMID: 21184129 DOI: 10.1007/s00011-010-0296-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
381 Saha S, Jing X, Park SY, Wang S, Li X, Gupta D, Dziarski R. Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma. Cell Host Microbe 2010;8:147-62. [PMID: 20709292 DOI: 10.1016/j.chom.2010.07.005] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 7.4] [Reference Citation Analysis]
382 Engel DR, Koscielny A, Wehner S, Maurer J, Schiwon M, Franken L, Schumak B, Limmer A, Sparwasser T, Hirner A, Knolle PA, Kalff JC, Kurts C. T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract. Nat Med 2010;16:1407-13. [PMID: 21113155 DOI: 10.1038/nm.2255] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
383 Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, Ziebell K, Torres AG, Karmali MA, Coombes BK. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667. [PMID: 21108814 DOI: 10.1186/1471-2164-11-667] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 9.6] [Reference Citation Analysis]
384 Choi J, Bae S, Hong J, Ryoo S, Jhun H, Hong K, Yoon D, Lee S, Her E, Choi W, Kim J, Azam T, Dinarello CA, Kim S. Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. Proc Natl Acad Sci U S A 2010;107:21082-6. [PMID: 21078994 DOI: 10.1073/pnas.1015418107] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
385 Eckhardt ER, Witta J, Zhong J, Arsenescu R, Arsenescu V, Wang Y, Ghoshal S, de Beer MC, de Beer FC, de Villiers WJ. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol 2010;10:133. [PMID: 21067563 DOI: 10.1186/1471-230X-10-133] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
386 Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC, Al-Shamkhani A. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol 2011;4:186-96. [PMID: 20962771 DOI: 10.1038/mi.2010.70] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
387 Kriegel C, Amiji M. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. J Control Release 2011;150:77-86. [PMID: 20959130 DOI: 10.1016/j.jconrel.2010.10.002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 108] [Article Influence: 10.5] [Reference Citation Analysis]
388 Gorfu G, Rivera-Nieves J, Hoang S, Abbott DW, Arbenz-Smith K, Azar DW, Pizarro TT, Cominelli F, McDuffie M, Ley K. Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice. J Immunol 2010;185:5561-8. [PMID: 20926792 DOI: 10.4049/jimmunol.0903938] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
389 Pearson JP, Brownlee IA. The interaction of large bowel microflora with the colonic mucus barrier. Int J Inflam 2010;2010:321426. [PMID: 21152122 DOI: 10.4061/2010/321426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
390 Rolhion N, Barnich N, Bringer MA, Glasser AL, Ranc J, Hébuterne X, Hofman P, Darfeuille-Michaud A. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut 2010;59:1355-62. [PMID: 20587550 DOI: 10.1136/gut.2010.207456] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
391 Takebayashi K, Koboziev I, Ostanin DV, Gray L, Karlsson F, Robinson-Jackson SA, Kosloski-Davidson M, Dooley AB, Zhang S, Grisham MB. Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis. Inflamm Bowel Dis 2011;17:268-78. [PMID: 20812332 DOI: 10.1002/ibd.21447] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
392 Nitto DD, Sarra M, Pallone F, Monteleone G. Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol 2010; 16(29): 3638-3641 [PMID: 20677335 DOI: 10.3748/wjg.v16.i29.3638] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
393 Tannock GW. The bowel microbiota and inflammatory bowel diseases. Int J Inflam 2010;2010:954051. [PMID: 21188223 DOI: 10.4061/2010/954051] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
394 Brandon JA, Perez J, Jennings CD, Cohen DA, Sindhava VJ, Bondada S, Kaplan AM, Bryson JS. Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease. Am J Physiol Gastrointest Liver Physiol 2010;299:G602-13. [PMID: 20634434 DOI: 10.1152/ajpgi.00511.2009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
395 Mustafi D, Fan X, Dougherty U, Bissonnette M, Karczmar GS, Oto A, Hart J, Markiewicz E, Zamora M. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn Reson Med. 2010;63:922-929. [PMID: 20373393 DOI: 10.1002/mrm.22229] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
396 Knoch B, Barnett MP, Cooney J, McNabb WC, Barraclough D, Laing W, Zhu S, Park ZA, Maclean P, Knowles SO, Roy NC. Molecular Characterization of the Onset and Progression of Colitis in Inoculated Interleukin-10 Gene-Deficient Mice: A Role for PPARalpha. PPAR Res 2010;2010:621069. [PMID: 20671959 DOI: 10.1155/2010/621069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
397 Mizoguchi A, Mizoguchi E. Animal models of IBD: linkage to human disease. Curr Opin Pharmacol 2010;10:578-87. [PMID: 20860919 DOI: 10.1016/j.coph.2010.05.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
398 Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 2011;56:376-386. [PMID: 20521112 DOI: 10.1007/s10620-010-1286-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
399 Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, Posovszky C, Hoy L, Hornef MW. Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics 2010;125:e1433-40. [PMID: 20478942 DOI: 10.1542/peds.2009-2260] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 13.8] [Reference Citation Analysis]
400 Andersen V, Ernst A, Christensen J, Østergaard M, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet 2010;11:82. [PMID: 20509889 DOI: 10.1186/1471-2350-11-82] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
401 Feng T, Wang L, Schoeb TR, Elson CO, Cong Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010;207:1321-32. [PMID: 20498021 DOI: 10.1084/jem.20092253] [Cited by in Crossref: 155] [Cited by in F6Publishing: 158] [Article Influence: 12.9] [Reference Citation Analysis]
402 Li X, Liu X, Zou Y, Ouyang C, Wu X, Zhou M, Chen L, Ye L, Lu F. Predictors of clinical and endoscopic findings in differentiating Crohn's disease from intestinal tuberculosis. Dig Dis Sci 2011;56:188-96. [PMID: 20467901 DOI: 10.1007/s10620-010-1231-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
403 Szitter I, Pozsgai G, Sandor K, Elekes K, Kemeny A, Perkecz A, Szolcsanyi J, Helyes Z, Pinter E. The role of transient receptor potential vanilloid 1 (TRPV1) receptors in dextran sulfate-induced colitis in mice. J Mol Neurosci. 2010;42:80-88. [PMID: 20411352 DOI: 10.1007/s12031-010-9366-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
404 Arnett HA, Viney JL. Gatekeepers of intestinal inflammation. Inflamm Res 2010;59:1-14. [PMID: 20066780 DOI: 10.1007/s00011-009-0091-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
405 Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 2010;705:40-59. [PMID: 20298806 DOI: 10.1016/j.mrrev.2010.03.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
406 Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol. 2010;45:571-583. [PMID: 20213337 DOI: 10.1007/s00535-010-0219-3] [Cited by in Crossref: 124] [Cited by in F6Publishing: 127] [Article Influence: 10.3] [Reference Citation Analysis]
407 Iablokov V, Sydora BC, Foshaug R, Meddings J, Driedger D, Churchill T, Fedorak RN. Naturally occurring glycoalkaloids in potatoes aggravate intestinal inflammation in two mouse models of inflammatory bowel disease. Dig Dis Sci 2010;55:3078-85. [PMID: 20198430 DOI: 10.1007/s10620-010-1158-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
408 Boulard O, Asquith MJ, Powrie F, Maloy KJ. TLR2-independent induction and regulation of chronic intestinal inflammation. Eur J Immunol 2010;40:516-24. [PMID: 19950179 DOI: 10.1002/eji.200939669] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
409 Chen DF, Gong BD, Xie Q, Ben QW, Liu J, Yuan YZ. MicroRNA155 is induced in activated CD4+ T cells of TNBS-induced colitis in mice. World J Gastroenterol 2010; 16(7): 854-861 [PMID: 20143464 DOI: 10.3748/wjg.v16.i7.854] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
410 Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep. 2009;11:481-487. [PMID: 19903424 DOI: 10.1007/s11894-009-0073-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
411 Pandolfi F, Cianci R, Pagliari D, Landolfi R, Cammarota G. Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm 2009;2009:132028. [PMID: 20169125 DOI: 10.1155/2009/132028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
412 Borcherding F, Nitschke M, Hundorfean G, Rupp J, von Smolinski D, Bieber K, van Kooten C, Lehnert H, Fellermann K, Büning J. The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol 2010;176:1816-27. [PMID: 20133813 DOI: 10.2353/ajpath.2010.090461] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
413 Melillo JA, Song L, Bhagat G, Blazquez AB, Plumlee CR, Lee C, Berin C, Reizis B, Schindler C. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol 2010;184:2638-45. [PMID: 20124100 DOI: 10.4049/jimmunol.0902960] [Cited by in Crossref: 132] [Cited by in F6Publishing: 142] [Article Influence: 11.0] [Reference Citation Analysis]
414 Otsuka M, Kang YJ, Ren J, Jiang H, Wang Y, Omata M, Han J. Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 2010;138:1255-65, 1265.e1-9. [PMID: 20080092 DOI: 10.1053/j.gastro.2010.01.005] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
415 Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009;9:874-85. [PMID: 19935676 DOI: 10.1038/nrc2761] [Cited by in Crossref: 804] [Cited by in F6Publishing: 839] [Article Influence: 67.0] [Reference Citation Analysis]
416 Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, Augenlicht L, Lin EY. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol 2010;176:952-67. [PMID: 20042677 DOI: 10.2353/ajpath.2010.090622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
417 Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, Augenlicht L, Lin EY. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol. 2010;176:952-967. [PMID: 20042677 DOI: 10.2353/ajpath.2010.090622] [Cited by in Crossref: 146] [Cited by in F6Publishing: 146] [Article Influence: 11.2] [Reference Citation Analysis]
418 Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol. 2010;45:9-16. [PMID: 19960355 DOI: 10.1007/s00535-009-0138-3] [Cited by in Crossref: 119] [Cited by in F6Publishing: 115] [Article Influence: 9.2] [Reference Citation Analysis]
419 Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9:778-788. [PMID: 19855404 DOI: 10.1038/nri2655] [Cited by in Crossref: 368] [Cited by in F6Publishing: 377] [Article Influence: 28.3] [Reference Citation Analysis]
420 Takeda S, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Yokosuka O, Saito Y. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis. Dig Dis Sci. 2010;55:1886-1895. [PMID: 19908144 DOI: 10.1007/s10620-009-0974-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
421 Onyeagocha C, Hossain MS, Kumar A, Jones RM, Roback J, Gewirtz AT. Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol. 2009;175:2034-2042. [PMID: 19815702 DOI: 10.2353/ajpath.2009.090471] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
422 Ye JH, Rajendran VM. Adenosine: An immune modulator of inflammatory bowel diseases. World J Gastroenterol 2009; 15(36): 4491-4498 [PMID: 19777607 DOI: 10.3748/wjg.15.4491] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
423 Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010;12:99-113. [PMID: 19747213 DOI: 10.1111/j.1462-5822.2009.01381.x] [Cited by in Crossref: 218] [Cited by in F6Publishing: 210] [Article Influence: 16.8] [Reference Citation Analysis]
424 Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn’s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 2010;12:99-113. [PMID: 19747213 DOI: 10.1111/j.1462-5822.2009.01381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
425 Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, Darfeuille-Michaud A. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009;206:2179-2189. [PMID: 19737864 DOI: 10.1084/jem.20090741] [Cited by in Crossref: 198] [Cited by in F6Publishing: 199] [Article Influence: 15.2] [Reference Citation Analysis]
426 Wang D, Dubois RN, Richmond A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol. 2009;9:688-696. [PMID: 19734090 DOI: 10.1016/j.coph.2009.08.003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
427 Gorfu G, Rivera-nieves J, Ley K. . CMM 2009;9:836-50. [DOI: 10.2174/156652409789105525] [Cited by in Crossref: 203] [Cited by in F6Publishing: 199] [Article Influence: 15.6] [Reference Citation Analysis]
428 Markowitz J, Kugathasan S, Dubinsky M, Mei L, Crandall W, LeLeiko N, Oliva-Hemker M, Rosh J, Evans J, Mack D. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis. 2009;15:714-719. [PMID: 19107777 DOI: 10.1002/ibd.20831] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
429 Wu R, Dong W, Qiang X, Wang H, Blau SA, Ravikumar TS, Wang P. Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit Care Med 2009;37:2421-6. [PMID: 19531942 DOI: 10.1097/CCM.0b013e3181a557a2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
430 Sullivan S, Alex P, Dassopoulos T, Zachos NC, Iacobuzio-Donahue C, Donowitz M, Brant SR, Cuffari C, Harris ML, Datta LW, Conklin L, Chen Y, Li X. Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis 2009;15:261-74. [PMID: 18942765 DOI: 10.1002/ibd.20743] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 7.1] [Reference Citation Analysis]
431 Peña JA, Thompson-Snipes L, Calkins PR, Tatevian N, Puppi M, Finegold MJ. Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis. Inflamm Bowel Dis 2009;15:248-60. [PMID: 19037851 DOI: 10.1002/ibd.20744] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
432 Treede I, Braun A, Jeliaskova P, Giese T, Füllekrug J, Griffiths G, Stremmel W, Ehehalt R. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol 2009;9:53. [PMID: 19594939 DOI: 10.1186/1471-230X-9-53] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
433 Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009;104:1745-53. [PMID: 19471251 DOI: 10.1038/ajg.2009.225] [Cited by in Crossref: 133] [Cited by in F6Publishing: 134] [Article Influence: 10.2] [Reference Citation Analysis]
434 Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206:1465-1472. [PMID: 19564350 DOI: 10.1084/jem.20082683] [Cited by in Crossref: 661] [Cited by in F6Publishing: 668] [Article Influence: 50.8] [Reference Citation Analysis]
435 Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Escourrou J, Cartier C, Chaumaz G, Leveque M. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Pathol. 2009;175:207-214. [PMID: 19528350 DOI: 10.2353/ajpath.2009.080986] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
436 Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2009;15:341-352. [PMID: 18942757 DOI: 10.1002/ibd.20753] [Cited by in Crossref: 493] [Cited by in F6Publishing: 495] [Article Influence: 37.9] [Reference Citation Analysis]
437 Monteleone I, Pallone F, Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm. 2009;2009:297645. [PMID: 19503799 DOI: 10.1155/2009/297654] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
438 Monteleone I, Pallone F, Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm 2009;2009:297645. [PMID: 19503799 DOI: 10.1155/2009/297645] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
439 Olsen I, Tollefsen S, Aagaard C, Reitan LJ, Bannantine JP, Andersen P, Sollid LM, Lundin KE. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn’s disease patients. PLoS One. 2009;4:e5641. [PMID: 19479064 DOI: 10.1371/journal.pone.0005641] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
440 Antunes DM, da Costa JP, Campos SM, Paschoal PO, Garrido V, Siqueira M, Teixeira GA, Cardoso GP. The serum D-xylose test as a useful tool to identify malabsorption in rats with antigen specific gut inflammatory reaction. Int J Exp Pathol 2009;90:141-7. [PMID: 19335552 DOI: 10.1111/j.1365-2613.2008.00627.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
441 Fletcher CM, Coyne MJ, Villa OF, Chatzidaki-Livanis M, Comstock LE. A general O-glycosylation system important to the physiology of a major human intestinal symbiont. Cell. 2009;137:321-331. [PMID: 19379697 DOI: 10.1016/j.cell.2009.02.041] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
442 Saurer L, Mueller C. T cell-mediated immunoregulation in the gastrointestinal tract. Allergy 2009;64:505-19. [PMID: 19210347 DOI: 10.1111/j.1398-9995.2009.01965.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
443 Visekruna A, Slavova N, Dullat S, Gröne J, Kroesen AJ, Ritz JP, Buhr HJ, Steinhoff U. Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease. Int J Colorectal Dis 2009;24:1133-9. [PMID: 19274467 DOI: 10.1007/s00384-009-0679-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
444 Xie F. Expression of soluble CD40L in inflammatory bowel disease and its clinical significance. Shijie Huaren Xiaohua Zazhi 2009; 17(7): 737-739 [DOI: 10.11569/wcjd.v17.i7.737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103-113. [PMID: 19185845 DOI: 10.1016/j.ccr.2009.01.001] [Cited by in Crossref: 1367] [Cited by in F6Publishing: 1355] [Article Influence: 105.2] [Reference Citation Analysis]
446 Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One 2009;4:e4562. [PMID: 19234608 DOI: 10.1371/journal.pone.0004562] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
447 Harris NR, Whatley JR, Carter PR, Morgan GA, Grisham MB. Altered microvascular hemodynamics during the induction and perpetuation of chronic gut inflammation. Am J Physiol Gastrointest Liver Physiol 2009;296:G750-4. [PMID: 19221013 DOI: 10.1152/ajpgi.90702.2008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
448 Chen GY, Shaw MH, Redondo G, Núñez G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res 2008;68:10060-7. [PMID: 19074871 DOI: 10.1158/0008-5472.CAN-08-2061] [Cited by in Crossref: 159] [Cited by in F6Publishing: 162] [Article Influence: 12.2] [Reference Citation Analysis]
449 Xia XZ, Liu ZJ. IL-21 receptor is highly expressed and induces proinflammatory cytokine secretion in patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2009; 17(1): 102-105 [DOI: 10.11569/wcjd.v17.i1.102] [Reference Citation Analysis]
450 Mannon PJ, Leon F, Fuss IJ, Walter BA, Begnami M, Quezado M, Yang Z, Yi C, Groden C, Friend J. Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells. Clin Exp Immunol. 2009;155:447-456. [PMID: 19094118 DOI: 10.1111/j.1365-2249.2008.03799.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
451 Sollid LM, Johansen FE. Animal models of inflammatory bowel disease at the dawn of the new genetics era. PLoS Med. 2008;5:e198. [PMID: 18828669 DOI: 10.1371/journal.pmed.0050198] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
452 Keely S, Ryan SM, Haddleton DM, Limer A, Mantovani G, Murphy EP, Colgan SP, Brayden DJ. Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers. J Control Release 2009;135:35-43. [PMID: 19110018 DOI: 10.1016/j.jconrel.2008.12.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
453 Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008;125:145-153. [PMID: 18798918 DOI: 10.1111/j.1365-2567.2008.02939.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.8] [Reference Citation Analysis]
454 Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008;125:145-153. [PMID: 18798918 DOI: 10.1111/j.1365-2567.2008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
455 Bai A, Guo Y, Shen Y, Xie Y, Zhu X, Lu N. Seasonality in flares and months of births of patients with ulcerative colitis in a Chinese population. Dig Dis Sci 2009;54:1094-8. [PMID: 19051033 DOI: 10.1007/s10620-008-0453-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
456 Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009;296:G135-46. [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008] [Cited by in Crossref: 280] [Cited by in F6Publishing: 264] [Article Influence: 20.0] [Reference Citation Analysis]
457 Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80. [PMID: 19026645 DOI: 10.1053/j.gastro.2008.10.080] [Cited by in Crossref: 806] [Cited by in F6Publishing: 743] [Article Influence: 57.6] [Reference Citation Analysis]
458 Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337-349. [PMID: 18854238 DOI: 10.1016/j.chom.2008.09.009] [Cited by in Crossref: 1119] [Cited by in F6Publishing: 1124] [Article Influence: 79.9] [Reference Citation Analysis]
459 Chen X, Feng BS, Zheng PY, Liao XQ, Chong J, Tang SG, Yang PC. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine. Am J Pathol. 2008;173:1647-1656. [PMID: 18974296 DOI: 10.2353/ajpath.2008.080487] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
460 Srikanth CV, McCormick BA. Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip Perspect Infect Dis. 2008;2008:626827. [PMID: 19259328 DOI: 10.1155/2008/626827] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
461 Chichlowski M, Hale LP. Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol. 2008;295:G1139-G1149. [PMID: 18927210 DOI: 10.1152/ajpgi.90516.2008] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
462 Guarner F. What is the role of the enteric commensal flora in IBD?: . Inflammatory Bowel Diseases 2008;14:S83-4. [DOI: 10.1097/00054725-200810001-00043] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
463 Moreira LO, Smith AM, DeFreitas AA, Qualls JE, El Kasmi KC, Murray PJ. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2. Vaccine 2008;26:5808-13. [PMID: 18789992 DOI: 10.1016/j.vaccine.2008.08.038] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
464 Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep. 2008;10:396-403. [PMID: 18627653 DOI: 10.1007/s11894-008-0075-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
465 Dong WY, Hu GZ, Zhang B, Zheng CQ, Chen SN, Liu WL, Shi YD. Effects of twelve Chinese herbs on human regulatory T cell differentiation in vitro. Shijie Huaren Xiaohua Zazhi 2008; 16(24): 2770-2774 [DOI: 10.11569/wcjd.v16.i24.2770] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
466 Ma JC, Zhang XL, Hao LS, Liu N. Advances in vitamin D and inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2008; 16(23): 2637-2643 [DOI: 10.11569/wcjd.v16.i23.2637] [Reference Citation Analysis]
467 Weigmann B, Lehr HA, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Schmidt J, Galle PR, Rose-John S, Neurath MF. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 2008;205:2099-110. [PMID: 18710929 DOI: 10.1084/jem.20072484] [Cited by in Crossref: 73] [Cited by in F6Publishing: 99] [Article Influence: 5.2] [Reference Citation Analysis]
468 Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One. 2008;3:e2629. [PMID: 18612433 DOI: 10.1371/journal.pone.0002629] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
469 Moreira LO, El Kasmi KC, Smith AM, Finkelstein D, Fillon S, Kim YG, Núñez G, Tuomanen E, Murray PJ. The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 2008;10:2067-77. [PMID: 18549453 DOI: 10.1111/j.1462-5822.2008.01189.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 4.7] [Reference Citation Analysis]
470 Shuvy M, Hershcovici T, Lull-Noguera C, Wichers H, Danay O, Levanon D, Zolotarov L, Ilan Y. Intrahepatic CD8+ lymphocyte trapping during tolerance induction using mushroom derived formulations: A possible role for liver in tolerance induction. World J Gastroenterol 2008; 14(24): 3872-3878 [PMID: 18609712 DOI: 10.3748/wjg.14.3872] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
471 Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep. 2007;9:497-507. [PMID: 18377803 DOI: 10.1007/s11894-007-0066-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 5.5] [Reference Citation Analysis]
472 Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008;29:369-375. [PMID: 18561994 DOI: 10.1016/j.mam.2008.04.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 6.1] [Reference Citation Analysis]
473 Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534-544. [PMID: 18172556 DOI: 10.1172/jci33194] [Cited by in Crossref: 142] [Cited by in F6Publishing: 483] [Article Influence: 10.1] [Reference Citation Analysis]
474 Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology. 2008;134:2036-2048, 2036-2048. [PMID: 18439915 DOI: 10.1053/j.gastro.2008.03.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 122] [Article Influence: 7.6] [Reference Citation Analysis]
475 Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. [PMID: 18297430 DOI: 10.1007/s00535-007-2111-3] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 8.4] [Reference Citation Analysis]
476 Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33-45. [PMID: 17923086 DOI: 10.1016/j.cell.2007.08.017] [Cited by in Crossref: 666] [Cited by in F6Publishing: 632] [Article Influence: 47.6] [Reference Citation Analysis]
477 Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 390-400 [PMID: 18200661 DOI: 10.3748/wjg.14.390] [Cited by in CrossRef: 120] [Cited by in F6Publishing: 124] [Article Influence: 8.6] [Reference Citation Analysis]
478 Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl). 2008;86:1395-1406. [PMID: 18064431 DOI: 10.1007/s00109-007-0290-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
479 Vijay-Kumar M, Aitken JD, Gewirtz AT. Toll like receptor-5: protecting the gut from enteric microbes. Semin Immunopathol 2008;30:11-21. [PMID: 18066550 DOI: 10.1007/s00281-007-0100-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
480 Klotz U, Teml A, Schwab M. Clinical pharmacokinetics and use of infliximab. Clin Pharmacokinet 2007;46:645-60. [PMID: 17655372 DOI: 10.2165/00003088-200746080-00002] [Cited by in Crossref: 166] [Cited by in F6Publishing: 160] [Article Influence: 11.1] [Reference Citation Analysis]
481 Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20:593-621. [PMID: 17934076 DOI: 10.1128/cmr.00008-07] [Cited by in Crossref: 872] [Cited by in F6Publishing: 973] [Article Influence: 58.1] [Reference Citation Analysis]
482 Sibilia J. Comment définir et classer les maladies inflammatoires? Revue du Rhumatisme 2007;74:714-25. [DOI: 10.1016/j.rhum.2007.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
483 Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, Wang Y, Bernstein X, Huang X, Reichardt LF, Bluestone JA, Sheppard D. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007;449:361-5. [PMID: 17694047 DOI: 10.1038/nature06110] [Cited by in Crossref: 378] [Cited by in F6Publishing: 367] [Article Influence: 25.2] [Reference Citation Analysis]